Stockwinners Market Radar for January 25, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
DNA | Hot Stocks20:33 EST Cathie Wood's ARK Investment bought 967K shares of Ginkgo Bioworks today
|
MSFT | Hot Stocks19:20 EST Xbox exclusive game 'Halo Infinite' achieves 20M players - According to the official "Halo" Twitter account, "Halo Infinite" has had the biggest launch in "Halo" franchise history, with over 20M players so far. "Halo" is a Microsoft-owned intellectual property, and "Infinite" is available on PC, Xbox One, and Xbox Series X/S. Reference Link
|
$BTC... | Hot Stocks19:13 EST Five Star Bank, NYDIG announce partnership over integrated bitcoin investment - Five Star Bank, a subsidiary of Financial Institutions, announced a new partnership with NYDIG, a bitcoin company. As a premier provider of consumer and commercial lending services across the Southern Tier, Finger Lakes, and Western regions of New York, the Bank will become one of the first financial institutions in the U.S. to enable its banking clients to securely buy, sell and hold bitcoin, powered by NYDIG. "We are thrilled to introduce a new-and trusted-digital banking option for customers to effortlessly acquire, sell, hold, and manage bitcoin alongside their traditional financial assets," said Martin K. Birmingham, CEO of Five Star Bank. "Thanks to NYDIG, we are creating a safe, efficient, and more user-friendly way for our customers to manage their digital transactions. Customer experience continues to be at the forefront of our focus at Five Star Bank, and we're proud to bring forth a crypto currency investment solution that will broaden access to this emerging portfolio option for consumers within our geographic footprint and, frankly, across the country."
|
GILD | Hot Stocks18:53 EST Gilead says FDA places partial clinical hold for studies on magrolimab combo - Gilead Sciences announced that the U.S. Food and Drug Administration has placed a partial clinical hold on studies evaluating the combination of magrolimab plus azacitidine due to an apparent imbalance in investigator-reported suspected unexpected serious adverse reactions between study arms. While no clear trend in the adverse reactions or new safety signal has been identified by Gilead at this time, the partial clinical hold is being implemented by Gilead across all ongoing magrolimab and azacitidine combination studies worldwide in the best interests of patients as additional data is gathered and analyzed to address the concerns raised by FDA. During the partial clinical hold, screening and enrollment of new study participants will be paused in any study investigating the combination of magrolimab with azacitidine. Patients already enrolled in these clinical studies may continue to receive magrolimab and azacitidine, or placebo, and continue to be closely monitored according to the current study protocol. Gilead is currently notifying clinical investigators and global regulatory authorities about the partial clinical hold. Other magrolimab studies, or cohorts, that are not studying the combination of magrolimab plus azacitidine, will continue without any impact by the partial clinical hold.
|
MSFT | Hot Stocks18:33 EST Microsoft says strong Azure forecast is based on global demand - Expects Azure to be volatile, but steady over time.
|
MSBI | Hot Stocks18:31 EST Midland States to acquire deposits and loans of two FNBC Bank & Trust locations - Midland States "announced the signing of a branch purchase and assumption agreement with FNBC Bank & Trust whereby Midland will acquire the deposits and certain loans and other assets associated with FNBC's branches in Mokena and Yorkville, Illinois. Midland will also acquire the Mokena branch location. The transaction is expected to close during the second quarter of 2022, subject to regulatory approval and other customary closing conditions. Prior to or upon closing of the transaction, FNBC intends to close the Yorkville branch, which is approximately one mile from Midland's existing Yorkville branch. Midland will continue operating the Mokena location as well as its existing Yorkville location following the completion of the transaction."
|
MSFT | Hot Stocks18:13 EST Microsoft sees Q3 Productivity and Business Processes revenue $15.6B-$15.85B - Sees Q3: More Personal Computing revenue $14.15B-$14.45B; Intelligent Cloud revenue $18.75B-$19B; Azure revenue growth up from Q2; CapEx slightly lower vs. Q2. Expects FX to lower revenue by 2%, COGS by 1%. Sees Q3 COGS $15.5B-$15.7B; OpEx $13.4B-$13.5B; Tax rate approximately 18%. Expects FY22 operating margin up slightly y/y. Guidance taken from Q2 earnings conference call.
|
UNP | Hot Stocks18:01 EST Loup Logistics acquires Precision Components transload facility - Loup Logistics Company, a wholly owned Union Pacific Railroad subsidiary, announced the acquisition of the Precision Components Inc. transload facility in Phoenix, Arizona. The deal was finalized December 30, 2021, and offers transloading, storage and trucking solutions to customers shipping into and out of the Phoenix market. PCI Reload is a premier transload facility located in the heart of Phoenix. The 100+-acre facility includes 125,000 square feet of covered storage and three miles of rail capacity, served by Union Pacific Railroad. The facility processes over 8,000 rail cars and 38,000 trucks annually. "PCI Reload helped fuel Arizona's economic growth by offering transloading, inventory management and final-destination shipping for a variety of industries," said Hal Owens, president - PCI Reload. "We believe Loup is well positioned to continue the PCI Reload tradition of exceeding customers' expectations."
|
DIS | Hot Stocks17:55 EST 'Percy Jackson' series in the works at Disney+ - "Percy Jackson and the Olympians" author Rick Riordan said in a video posted on the Disney+ Twitter account that a "Percy Jackson" series is in the works for Disney+. Riordan noted that James Bobin has signed on to direct the pilot episode. Reference Link
|
MSFT | Hot Stocks17:51 EST Microsoft says saw 'record engagement' in LinkedIn in Q2 - Says seeing Teams growth in every segment. Says seeing a "structural shift" in PC demand. Says "delighted" by response to Windows 11. Comments taken from Q2 earnings conference call.
|
BKEP | Hot Stocks17:43 EST Blueknight Energy Partners raises quarterly dividend by 6.3% to 4.25c per share - The fourth quarter 2021 distributions are payable on February 14, 2022, to unitholders of record as of the close of business on February 7, 2022.
|
ET | Hot Stocks17:26 EST Energy Transfer raises dividend 15% to 17.5c - Energy Transfer announced a quarterly cash distribution of 17.5 per Energy Transfer common unit, or 70c on an annualized basis, for the Q4 which will be paid on February 18 to unitholders of record as of the close of business on February 8. The distribution is an approximately 15% increase over the previous quarter and represents the first step in Energy Transfer's plan to return additional value to unitholders while maintaining its target leverage ratio of 4.0x-4.5x debt-to-EBITDA. Future increases to the distribution level will be evaluated quarterly with the ultimate goal of returning distributions to the previous level of 30.5 per quarter, or $1.22 on an annual basis, while balancing the partnership's leverage target, growth opportunities and unit buy-backs.
|
YSAC | Hot Stocks17:21 EST Yellowstone Acquisition, Sky Harbour close business combination - Yellowstone Acquisition Company and Sky Harbour LLC announced that they have closed their previously announced business combination. The business combination was approved by Yellowstone's stockholders at a special meeting held on January 25, 2022. Upon completion of the business combination on January 25, 2022, the combined company changed its name to Sky Harbour Group Corporation. Sky Harbour's Class A common stock will begin trading on the NYSE American under the ticker symbol "SKYH" commencing January 26, 2022. The warrants sold as part of the units in the Yellowstone IPO will also begin trading on the NYSE American under the ticker symbol "SKYHWS" commencing January 26, 2022.
|
CETX | Hot Stocks17:10 EST Cemtrex receives Nasdaq listing delinquency letter - Cemtrex announced that it received a letter from Listing Qualification Department of Nasdaq January 19, 2022, Cemtrex, Inc. received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the company that, because the company had not yet filed its Form 10-K for the period ended September 30, 2021, the company no longer complies with Nasdaq's Listing Rules 5250(c)(1) "Obligation to File Periodic Financial Reports" for continued listing. Per Nasdaq's rules the company is required to make a disclosure about the receipt of the delinquency letter.
|
WAFD | Hot Stocks17:01 EST Washington Federal raises quarterly dividend to 24c from 23c per share - The dividend will be paid February 18, 2022 to common shareholders of record as of February 4, 2022.
|
SND | Hot Stocks16:34 EST Smart Sand begins operations at terminal in Waynesburg - Smart Sand announced that it has commenced operations and is delivering sand to its newly-constructed, unit-train-capable transloading terminal in Waynesburg, Pennsylvania. The terminal has more than four miles of track, is located on Norfolk Southern's Class 1 rail line, services the southwestern portion of the Marcellus Basin and is expected to have transloading capacity in excess of one million tons of frac sand per year. The terminal will also serve as the Company's new Northeastern hub for its SmartSystem last-mile storage and transloading solutions.
|
MRUS NVS | Hot Stocks16:34 EST Merus names Shannon Campbell as Chief Commercial Officer - Merus N.V. (MRUS) "announced the appointment of Shannon Campbell as Executive Vice President & Chief Commercial Officer. Ms. Campbell brings over 25 years of pharmaceutical commercialization experience and joins Merus from Novartis Pharmaceuticals, where she led Novartis's (NVS) U.S. Oncology Solid Tumor Franchise and was responsible for a broad portfolio of therapies in oncology and rare diseases."
|
CADE | Hot Stocks16:33 EST Cadence Bank increases quarterly dividend 10% - The board declared quarterly cash dividends of 22c per common share of stock and 34.375c per share of Series A Preferred Stock. The common stock dividend represents an increase of 2c, or 10%, per share compared to the previous quarterly dividend of 20c per common share and is payable on April 1 to shareholders of record at the close of business on March 15. The preferred stock dividend is payable on February 22 to shareholders of record at the close of business on February 4.
|
DSS | Hot Stocks16:32 EST DSS receives $17M investment from Alset EHome - DSS, Inc. entered into a stock purchase agreement with Alset EHome International pursuant to which the company agreed to issue to up to 44,619,423 shares of the company's common stock for a purchase price of $0.3810 per share. If required by the rules and regulations of the NYSE American, LLC, the issuance of the shares will be subject to the approval of the company's shareholders. "This is a strong vote of confidence from our majority shareholder, Alset EHome International," stated Frank D. Heuszel, DSS CEO. "The further strengthening of our balance sheet with this latest cash infusion will enable us to more rapidly capitalize on the wealth of available opportunities across our diverse business lines."
|
INCY | Hot Stocks16:32 EST Incyte withdraws NDA for parsaclisib, opts out from further MCLA-145 development - Incyte "announced updates regarding the clinical development of parsaclisib, the Company's next-generation oral inhibitor of phosphatidylinositol 3-kinase delta (PI3Kdelta), and MCLA-145, its CD137/PD-L1 bispecific antibody co-developed under a global collaboration and license agreement with Merus. Incyte is withdrawing the New Drug Application for parsaclisib for the treatment of patients with relapsed or refractory follicular lymphoma , marginal zone lymphoma and mantle cell lymphoma. The decision to withdraw the NDA follows discussions with U.S. Food and Drug Administration regarding confirmatory studies to support an accelerated approval, which Incyte determined cannot be completed within a time period that would support the investment. The withdrawal of the NDA is a business decision and is not related to any changes in either the efficacy or safety of parsaclisib. The decision impacts only the FL, MZL and MCL indications in the U.S., and does not affect other ongoing clinical trials in the U.S. or other countries. Additionally, as part of its ongoing portfolio prioritization and capital allocation review, Incyte has decided to opt-out of the continued development of MCLA-145. Incyte will continue to collaborate with Merus and leverage their platform to develop a pipeline of novel agents."
|
CNI | Hot Stocks16:31 EST Canadian National reaches resolution agreement with TCI - CN announced that it has entered into a Resolution Agreement with CIFF Capital and TCI. Earlier, CN announced several changes to its Board including committing to appoint two new independent Directors to the Board by no later than CN's 2022 Annual General Meeting. The appointments of the two future independent directors to the Board have been mutually agreed between CN and TCI in the Resolution Agreement. As part of that Resolution Agreement, TCI has agreed to withdraw its requisition for a Special Meeting of Shareholders, which was previously scheduled to be held on March 22, and to support the election of all CN Director nominees at the 2022 and 2023 AGMs. In the event that either of the two new independent directors are unable to serve on the Board, CN and TCI have agreed, on a mutual agreement basis, to identify up to two alternate independent Directors with North American railroad experience prior to the 2022 AGM.
|
CNI | Hot Stocks16:30 EST Canadian National names Tracy Robinson as CEO, effective February 28 - CN announced that it has appointed Tracy Robinson as President and CEO and as a member of its Board of Directors, effective February 28. This appointment follows the previously announced retirement of Jean-Jacques Ruest, who will depart CN's Board on February 28, but remain at CN in an advisory role until March 31 to ensure a seamless transition. Robinson will be joining CN from TC Energy. CN also announced several changes to its Board of Directors. The company has appointed The Hon. Jean Charest P.C. as an independent Director. Shauneen Bruder has been appointed Vice Chair of the Board. By no later than CN's 2022 Annual General Meeting, CN will appoint two new independent Directors with North American railroad experience to the Board.
|
WNEB | Hot Stocks16:24 EST Western New England Bancorp raises dividend 20% to 6c per share - The Company announced that the Board of Directors declared a quarterly cash dividend of 6c per share on its common stock, representing an increase of 1c per share, or 20%, as compared to the prior quarter. The dividend will be payable on or about February 23 to shareholders of record on February 9, ."We are pleased to announce record results for the Company for 2021 along with a strong fourth quarter," said James C. Hagan, President and Chief Executive Officer. "In 2021, the Company saw significant loan production, increased PPP fees, lower cost of funds and asset quality metrics that achieved historical lows. These results were highlighted by increases in our low-cost core deposit categories, with core deposits as a whole increasing $402 million, or 27.7%, as well as increases in our commercial and residential lending production. Our fourth quarter results represent our continuing sound balance sheet management and net interest margin stabilization. As we emerge from the pandemic, we are able to focus on more traditional and profitable banking activities, which assisted the Company in achieving record profitability in 2021.
|
OFC | Hot Stocks16:20 EST Corporate Office Properties sells DC-6 for $222.5M - Corporate Office Properties announces that it "has sold 100% of COPT DC-6, or DC-6, the only asset in the Company's Wholesale Data Center reporting segment, to an investment vehicle managed by Cloud Capital, an affiliate company of CloudHQ, for $222.5M. There was no debt on the asset and the Company will recycle the proceeds into funding its 1.8 million square feet of development projects that, on September 30, 2021, were 94% leased."
|
WTTR NES | Hot Stocks16:19 EST Select Energy Services receives consent to acquisition of Nuverra Environmental - Select Energy Services (WTTR) and Nuverra Environmental Solutions (NES) announced that following the SEC declaring effective the Registration Statement on Form S-4 on January 19, 2022, the two largest Nuverra stockholders have delivered their written consents to approve and adopt the merger agreement among Nuverra, Select and wholly owned subsidiaries of Select. These stockholders, Ascribe II Investments, LLC, Ascribe III Investments, LLC and Gates Capital Management, own approximately 84% of Nuverra's outstanding common stock. While the consents of Ascribe and Gates are sufficient to approve the transaction, Nuverra is requesting all its common stockholders approve the merger and other proposals outlined in the Registration Statement by executing and returning the written consent furnished with the filing. Select and Nuverra expect the transaction to close in the first quarter of 2022, subject to the satisfaction of customary closing conditions.
|
PFC | Hot Stocks16:18 EST Premier Financial raises quarterly dividend 7% to 30c per share
|
PFC | Hot Stocks16:18 EST Premier Financial boosts share buyback authorization to 2M shares - At December 31, 2021, 1,032,864 common shares remained available for repurchase under the company's existing repurchase program. On January 25, 2021, the company's Board of Directors approved an increase in the company's repurchase authorization to 2,000,000 shares of common stock, or approximately 5.5% of current outstanding shares.
|
PLMR | Hot Stocks16:17 EST Palomar approves $100M share repurchase plan - Palomar announced that its board of directors has approved a share repurchase program effective January 24. The program replaces the previous share repurchase authorization that had $24.2M of the original $40M remaining and authorizes the repurchase by the company of up to $100M of its outstanding shares of common stock over the period ending on March 31, 2024
|
SB | Hot Stocks16:14 EST Safe Bulkers to acquire Capesize class vessel for $33.8M - Safe Bulkers announced that it has entered into an agreement for the acquisition of a 2014-built, Japanese, dry-bulk, 181,000 dwt, Capesize class vessel, to be named MV Maria, with a scheduled delivery date within February. The vessel will be acquired at a purchase price of $33.8M and will be financed from the cash reserves of the company.
|
CNI | Hot Stocks16:12 EST Canadian National announces C$5B normal course issuer bid - CN announced that its board of directors has approved the repurchase of its shares under a new normal course issuer bid, as well as a 19% increase in the 2022 dividend on the company's common shares outstanding. The bid, in the range of C$5B, permits CN to purchase, for cancellation, over a 12-month period up to 42M common shares, representing 6.80% of the 618,826,610 common shares issued and outstanding of the company not held by insiders on January 18. On that date, 701,740,872 CN common shares were issued and outstanding. CN's board of directors also approved a Q1 dividend on the company's common shares outstanding. A quarterly dividend of 73.25c per common share will be paid on March 31, to shareholders of record at the close of business on March 10.
|
HA | Hot Stocks16:10 EST Hawaiian Holdings lowers FY22 CapEx view to $105M-$125M from $365M-$385M - Lowers FY22 ASMs view to down 3%-up 1% from flat to up 4% from FY19 results.
|
TXN | Hot Stocks16:10 EST Texas Instruments jumps 6% to $184 after Q4 results, Q1 guidance beat estimates
|
FFIV | Hot Stocks16:09 EST F5 Networks falls 18% to $182 per share after cutting FY22 growth outlook
|
DASH NFLX | Hot Stocks16:08 EST DoorDash elects Greg Peters to board of directors - DoorDash (DASH) announced that Greg Peters, COO and Chief Product Officer of Netflix (NFLX), has been elected to the company's board of directors, effective January 19.
|
MSFT | Hot Stocks16:08 EST Microsoft down 4% after Q2 report - In after-hours trading following the company's Q2 report, Microsoft shares are down $11.89, or 4%, to $276.60.
|
MSFT | Hot Stocks16:07 EST Microsoft reports Q2 Productivity and Business Processes revenue up 19% - Revenue in Productivity and Business Processes was $15.9B and increased 19%. Office Commercial products and cloud services revenue increased 14% driven by Office 365 Commercial revenue growth of 19%. Office Consumer products and cloud services revenue increased 15% and Microsoft 365 Consumer subscribers grew to 56.4 million. LinkedIn revenue increased 37%, or up 36% in constant currency. Dynamics products and cloud services revenue increased 29% driven by Dynamics 365 revenue growth of 45%, or up 44% in constant currency.
|
COF | Hot Stocks16:07 EST Capital One reports Q4 net interest margin 6.60%, up 25 bps sequentially - Reports Q4: Provision for credit losses increased $723M to $381M: Net charge-offs of $527M; $145M loan reserve release.
|
MSFT | Hot Stocks16:06 EST Microsoft CEO says 'innovating and investing across diverse and growing markets' - "Digital technology is the most malleable resource at the world's disposal to overcome constraints and reimagine everyday work and life. As tech as a percentage of global GDP continues to increase, we are innovating and investing across diverse and growing markets, with a common underlying technology stack and an operating model that reinforces a common strategy, culture, and sense of purpose," said Satya Nadella, chairman and CEO of Microsoft.
|
MITC | Hot Stocks16:06 EST MeaTech 3D appoints Arik Kaufman as CEO - MeaTech 3D announced the following changes to its executive management team and Board of Directors: Sharon Fima announced that, in light of the Company's current stage of development, he intends to step down from the positions of CEO, Chief Technology Officer and Director in the near future. Fima intends to continue supporting the Company as a founding member of the Company's scientific advisory board. MeaTech's Board of Directors appointed Arik Kaufman to the position of CEO, effective upon Fima's departure. Kaufman has founded various Nasdaq- and TASE-traded foodtech companies, and currently serves as director of Wilk Technologies. He is also a founding partner of the BlueSoundWaves collective. Kaufman holds extensive personal experience in the fields of food-tech and bio-tech law, and has led and managed numerous complex commercial negotiations, as part of local and international fundraising, M&A transactions and licensing agreements. Steven H. Lavin and Danny Ayalon stepped down from MeaTech's Board of Directors effective January 24 in light of the Company's current stage of development and to pursue other ventures, and both outgoing directors expressed their ongoing support for MeaTech and its technologies. In addition, Omri Schanin stepped down from the Board of Directors and continues to serve as MeaTech's Deputy CEO. Yaron Kaiser was appointed to the Board of Directors of the Company as its Chairperson.
|
MSFT | Hot Stocks16:05 EST Microsoft says Cloud revenue of $22.1B up 32% year over year - Amy Hood, executive vice president and chief financial officer of Microsoft, said: "Solid commercial execution, represented by strong bookings growth driven by long-term Azure commitments, increased Microsoft Cloud revenue to $22.1 billion, up 32% year over year."
|
MSFT | Hot Stocks16:05 EST Microsoft reports Q2 More Personal Computing revenue up 15% to $17.5B - Revenue in More Personal Computing was $17.5B and increased 15%. Windows OEM revenue increased 25%. Windows Commercial products and cloud services revenue increased 13%, up 14% in constant currency. Xbox content and services revenue increased 10%. Search and news advertising revenue excluding traffic acquisition costs increased 32%. Surface revenue increased 8%.
|
MSFT | Hot Stocks16:04 EST Microsoft reports Q2 Intelligent Cloud revenue up 26% to $18.3B - Revenue in Intelligent Cloud was $18.3B and increased 26%. Server products and cloud services revenue increased 29% driven by Azure and other cloud services revenue growth of 46%.
|
TXN | Hot Stocks16:03 EST Texas Instruments CEO says strong demand in industrial and automotive markets - Regarding the company's performance and returns to shareholders, Rich Templeton, TI's chairman, president and CEO, made the following comments: "Revenue increased 19% from the same quarter a year ago driven by strong demand in industrial and automotive markets. Analog revenue grew 20% and Embedded Processing grew 6% from the year-ago quarter. Our cash flow from operations of $8.8 billion for the year again underscored the strength of our business model. Free cash flow for the year was $6.3 billion and 34% of revenue. This reflects the quality of our product portfolio, as well as the efficiency of our manufacturing strategy, including the benefit of 300-millimeter production. We returned $4.4 billion to owners in 2021 through dividends and stock repurchases. For the year, our dividend represented 62% of free cash flow, underscoring its sustainability. Together, our dividends and stock repurchases reflect our continued commitment to return all free cash flow to our owners. TI's first quarter outlook is for revenue in the range of $4.50 billion to $4.90 billion and earnings per share between $2.01 and $2.29. We expect our 2022 annual operating tax rate to be about 14%."
|
DCTH VCEL | Hot Stocks16:03 EST Delcath Systems appoints David Hoffman as general counsel, CCO - Delcath Systems (DCTH) announced that David Hoffman has been appointed as general counsel and corporate secretary. Hoffman will also serve as Delcath's chief compliance officer, or CCO. Hoffman brings over 20 years of experience advising biotechnology companies with a focus on the commercialization of therapies. Most recently, he served as associate general counsel and chief compliance officer at Vericel (VCEL), where he was responsible for legal and compliance matters and supported the launch and growth of products in the advanced cell therapy and biologics space.
|
DSS | Hot Stocks16:00 EST Document Security trading resumes
|
VMAC | Hot Stocks15:37 EST Vistas Media Acquisition Company Inc (Class A Stock) trading resumes
|
VMAC | Hot Stocks15:32 EST Vistas Media Acquisition Company Inc (Class A Stock) trading halted, volatility trading pause
|
DSS | Hot Stocks15:31 EST DSS reports stock purchase agreement with Alset EHome International - In a regulatory filing, DSS reported that on January 25, the company entered into a stock purchase agreement with Alset EHome International, pursuant to which the company agreed to issue to Alset EHome International, Inc. up to 44,619,423 shares of the company's common stock for a purchase price of 38.1c per share. "If required by the rules and regulations of the NYSE American, LLC, the issuance of the shares will be subject to the approval of the company's shareholders," the filing stated.
|
DSS | Hot Stocks15:16 EST Document Security trading halted, news pending
|
SNY | Hot Stocks14:59 EST Sanofi treatment of achondroplasia granted FDA orphan status - Sanofi-aventis' anti-fibroblast growth factor receptor 3 monoclonal antibody antigen-binding fragment was granted FDA orphan designation as a treatment of achondroplasia, according to a post to the agency's website. Reference Link
|
ATVI MSFT | Hot Stocks13:51 EST Blizzard working on untitled survival game for PC, console - Blizzard, a unit of Activision Blizzard (ATVI) responsible for the "Warcraft," "Diablo," and "Overwatch" franchises, announced that it is working on a new survival game for PC and console. "A place full of heroes we have yet to meet, stories yet to be told, and adventures yet to be lived," the company said. "A vast realm of possibility, waiting to be explored." The news comes a week after Activision Blizzard agreed to be acquired by Microsoft (MSFT) for $68.7B. Reference Link
|
WFC | Hot Stocks13:46 EST Wells Fargo raises quarterly dividend to 25c per share - Wells Fargo & Company announced a quarterly common stock dividend of 25c per share, payable March 1, 2022, to stockholders of record on Feb. 4, 2022, as approved today by the Wells Fargo board of directors. The first quarter dividend represents an increase of 5c per share from the prior quarter.
|
BALY | Hot Stocks13:39 EST Bally's jumps after Standard General offers $38 per share for remaining stake - Shares of Bally's are higher in afternoon trading after shareholder Standard General, which holds a 21% stake, disclosed in a regulatory filing earlier that on January 25, Standard General delivered a non-binding letter to the board of directors of the company proposing a transaction under which it would acquire all of the outstanding shares of common stock not currently owned by Standard General at a price of $38.00 per share. The filing stated in part: "As described in the proposal letter, Standard General expects that the Board of Directors of the company will appoint a special committee of independent directors to consider its proposal and make a recommendation to the Board of Directors. Standard General will not move forward with the transaction unless it is approved by such a special committee. In addition, the transaction will be subject to a non-waivable condition requiring the approval of holders of a majority of the shares of the company not owned by Standard General or its affiliates. No assurances can be given that a transaction will be consummated. The Proposal Letter provides that no legally binding obligation with respect to a transaction will exist unless and until mutually acceptable definitive documentation has been executed and delivered with respect thereto." In afternoon trading, Bally's shares have advanced $7.55, or 26%, to $36.78.
|
MOR | Hot Stocks13:30 EST MorphoSys CEO believes M&A will stay firmly on biopharma agenda in 2022
|
MOR | Hot Stocks13:30 EST MorphoSys CEO says Monjuvi feedback 'overwhelmingly positive'
|
MOR | Hot Stocks13:30 EST MorphoSys expects to have two commercial products available by 2025, CEO says
|
GOOG GOOGL | Hot Stocks12:52 EST Google introduces new Privacy Sandbox proposal Topics - Alphabet's Google announced Topics, a new Privacy Sandbox proposal for interest-based advertising. "Topics was informed by our learning and widespread community feedback from our earlier FLoC trials, and replaces our FLoC proposal," said Vinay Goel, product director of Privacy at Sandbox and Chrome. "With Topics, your browser determines a handful of topics, like "Fitness" or "Travel & Transportation," that represent your top interests for that week based on your browsing history. Topics are kept for only three weeks and old topics are deleted. Topics are selected entirely on your device without involving any external servers, including Google servers. When you visit a participating site, Topics picks just three topics, one topic from each of the past three weeks, to share with the site and its advertising partners. Topics enables browsers to give you meaningful transparency and control over this data, and in Chrome, we're building user controls that let you see the topics, remove any you don't like or disable the feature completely." Reference Link
|
EDR | Hot Stocks12:22 EST Jake Paul announces stake in Endeavor Group, contacts Engine No. 1 - Social media personality and professional boxer Jake Paul announced earlier via Twitter that he's investing in Endeavor Group, the parent of the Ultimate Fighting Championship. He added that he's reaching out to activist Engine No. 1 regarding the stake. Paul tweeted: "I've invested in EDR (UFC) stock with my partner @geoffreywoo 2 focus on UFCs ESG standards relating to fighters. We believe EDR can drive long-term economic value by increasing UFC fighter pay & providing them healthcare. Reaching out to @EngineNo_1 to partner on this "endeavor."
|
BTI... | Hot Stocks12:17 EST Philip Morris denied stay of order banning U.S. imports of IQOS - Philip Morris (PM) and partner Altria (MO) asked a U.S. appeals court to let them continue importing IQOS heated-tobacco sticks in the U.S. while they challenge a patent-infringement case won by Reynolds American (BTI) at the International Trade Commission, but the United States Court of Appeals for the Federal Circuit denied a motion for a stay. "Without prejudicing the ultimate disposition of the appeal, we conclude that the appellants have not established that a stay pending this appeal is warranted here," the U.S. Court of Appeals for the Federal Circuit stated in a ruling posted to its site.
|
PCAR | Hot Stocks12:15 EST Paccar sees Q1 truck and parts gross margins 13%-13.5% - Comments taken from Q4 earnings conference call.
|
WYNN | Hot Stocks12:01 EST WynnBET begins pre-registration in Louisiana - WynnBET announced that account pre-registration and deposit is now available in Louisiana. "WynnBET's launch in Louisiana is just the beginning of an exciting few months for our company as we significantly increase our footprint during the first quarter of 2022," Wynn Interactive President Ian Williams said. "Pending regulatory approval, we will also soon be launching our online sportsbook in New York and Iowa, expanding the number of states players can enjoy our platform from seven to 10. We look forward to welcoming new customers from across the country to WynnBET in the coming weeks." WynnBET is the online sports betting and casino app from Wynn Resorts.
|
ETRN | Hot Stocks12:01 EST Equitrans Midstream falls -12.1% - Equitrans Midstream is down -12.1%, or -$1.26 to $9.13.
|
HKIB | Hot Stocks12:01 EST AMTD International falls -15.6% - AMTD International is down -15.6%, or -67c to $3.63.
|
AJRD | Hot Stocks12:00 EST Aerojet Rocketdyne falls -18.5% - Aerojet Rocketdyne is down -18.5%, or -$8.31 to $36.69.
|
SOXS | Hot Stocks12:00 EST Direxion Daily Semiconductor Bear 3X Shares rises 11.4% - Direxion Daily Semiconductor Bear 3X Shares is up 11.4%, or 54c to $5.27.
|
TRQ | Hot Stocks12:00 EST Turquoise Hill rises 16.0% - Turquoise Hill is up 16.0%, or $2.41 to $17.51.
|
BALY | Hot Stocks12:00 EST Bally's rises 24.3% - Bally's is up 24.3%, or $7.10 to $36.33.
|
BRFH | Hot Stocks11:50 EST Barfresh Food Group Inc trading resumes
|
BRFH | Hot Stocks11:45 EST Barfresh Food Group Inc trading halted, volatility trading pause
|
ROG DD | Hot Stocks11:33 EST Rogers' shareholders approve acquisition by DuPont - Rogers Corporation (ROG) announced that at a special shareholder meeting held earlier, its shareholders voted to approve the previously announced acquisition of Rogers by DuPont de Nemours, Inc. (DD). Under the terms of the merger agreement, Rogers' shareholders will receive $277.00 in cash for every share of Rogers capital stock they own immediately prior to the effective time of the merger. The final voting results will be set forth in a Form 8-K filed by Rogers with the U.S. Securities and Exchange Commission. As previously disclosed, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired. The completion of the transaction remains subject to the satisfaction of other customary closing conditions, including receipt of certain non-U.S. regulatory approvals. The companies continue to expect that the transaction will close by the end of the second quarter of 2022.
|
LMT AJRD | Hot Stocks11:23 EST Lockheed Martin to decide next steps on Aerojet Rocketdyne deal within 30 days
|
AMD... | Hot Stocks11:15 EST Commerce Department study finds semi supply chain 'remains fragile' - In September, the Department of Commerce launched a request for information on the semiconductor supply chain and received more than 150 responses, including from "nearly every major semiconductor producer and from companies in multiple consuming industries." The semiconductor supply chain remains fragile. Demand continues to far outstrip supply," the agency said today in a report. Median demand for chips highlighted by buyers was as much as 17% higher in 2021 than 2019, and buyers aren't seeing commensurate increases in the supply they receive. "This is a major supply and demand mismatch," the Department of Commerce writes. The median inventory of semiconductor products highlighted by buyers has fallen from 40 days in 2019 to less than five days in 2021, it notes. "The primary bottleneck across the board appears to be wafer production capacity, which requires a longer-term solution. We're going to capitalize on this new information to engage industry on node-specific problem-solving in the coming weeks. We will also look into claims about unusually high prices in these nodes," the agency added. Publicly traded companies in the semiconductor space include AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN). Reference Link
|
NSC | Hot Stocks11:12 EST Norfolk Southern board increases quarterly dividend 14% to $1.24 per share - Norfolk Southern Corporation announced that its Board of Directors has approved a 14% increase in its quarterly dividend on the company's common stock, from $1.09 to $1.24 per share. "This increase in the dividend payment represents our confidence in the strength of the company and its prospects for long-term growth. Since our founding 40 years ago, we have been committed to providing our shareholders with a solid return on their investment," said James A. Squires, Norfolk Southern chairman and CEO. The dividend is payable February 21, 2022 to shareholders of record on February 4, 2022.
|
LMT | Hot Stocks11:09 EST Lockheed Martin plans to spend $4B on buybacks, dividends this year
|
GM | Hot Stocks11:07 EST GM sees more than 1 million units of electric vehicle capacity by end of 2025 - General Motors announced an investment of more than $7B in four Michigan manufacturing sites. As part of this announcement, GM said it is investing $4B to convert the Orion Assembly facility to produce electric trucks using the GM-developed Ultium Platform, which gives the company the flexibility to build vehicles for every customer and segment. "This investment is expected to create more than 2,350 new jobs at Orion and retain approximately 1,000 current jobs when the plant is fully operational. GM estimates the new jobs at Orion will be filled by a combination of GM transferees and new hires. Electric truck production, including the Chevrolet Silverado EV and electric GMC Sierra, will begin at Orion in 2024. The Orion investment will drive significant facility and capacity expansion at the site, including new body and paint shops and new general assembly and battery pack assembly areas. Production of the Chevrolet Bolt EV and EUV will continue during the plant's conversion. Site work begins immediately," GM said. In addition, GM and LG Energy Solution, via their Ultium Cells joint venture, are investing $2.6B to build Ultium Cells' third U.S. battery cell manufacturing plant. "This investment is expected to create more than 1,700 new Ultium Cells jobs when the plant is fully operational. Site preparations will begin this summer and battery cell production is scheduled to begin in late 2024. Ultium Cells Lansing will supply battery cells to Orion Assembly and other GM assembly plants," GM said. The company added: "Orion Assembly will become GM's third U.S. assembly plant being transformed for production of Ultium-powered EVs. GM assembly plants in North America currently building, or being converted to build EVs, include Factory ZERO in Detroit and Hamtramck, Michigan; Spring Hill Assembly in Spring Hill, Tennessee; CAMI in Ingersoll, Ontario and Ramos Arizpe Assembly in Mexico. By the end of 2025, GM will have more than 1 million units of electric vehicle capacity in North America to respond to growing electric vehicle demand."
|
LMT AJRD | Hot Stocks11:05 EST Lockheed Martin to evaluate 'all of our options' with filing of FTC lawsuit
|
STLD | Hot Stocks11:04 EST Steel Dynamics 'incredibly optimistic' for 2022, says CEO Mark Millett - Comments taken from Q4 earnings conference call.
|
LMT AJRD | Hot Stocks11:03 EST Lockheed Martin has received notification that FTC has authorized filing lawsuit - Lockheed Martin (LMT) said it may elect to fight lawsuit or terminate merger agreement with Aerojet Rocketdyne (AJRD). Comments taken from Q4 earnings conference call.
|
GM | Hot Stocks11:03 EST GM announces investment of more than $7B in four Michigan manufacturing sites - General Motors announced an investment of more than $7B in four Michigan manufacturing sites that it said will create 4,000 new jobs and retain 1,000 while "significantly increasing battery cell and electric truck manufacturing capacity." GM said: "This is the single largest investment announcement in GM history. The investment includes construction of a new Ultium Cells battery cell plant in Lansing and the conversion of GM's assembly plant in Orion Township, Michigan for production of the Chevrolet Silverado EV and the electric GMC Sierra, GM's second assembly plant scheduled to build full-size electric pickups." Mary Barra, GM Chair and CEO, added: "Today we are taking the next step in our continuous work to establish GM's EV leadership by making investments in our vertically integrated battery production in the U.S., and our North American EV production capacity. We are building on the positive consumer response and reservations for our recent EV launches and debuts, including GMC HUMMER EV, Cadillac LYRIQ, Chevrolet Equinox EV and Chevrolet Silverado EV. Our plan creates the broadest EV portfolio of any automaker and further solidifies our path toward U.S. EV leadership by mid-decade." The company said that vertically integrating battery assembly and converting existing assembly plants are at the core of GM's strategy for scaling EV production in North America. GM projects it will convert 50% of its North American assembly capacity to EV production by 2030.
|
ADM | Hot Stocks11:01 EST ADM board increases quarterly dividend 8.1% to 40c per share - ADM's Board of Directors has declared a cash dividend of 40c per share on the company's common stock, an 8.1% increase from last quarter's dividend of 37c per share. "Last month, at our Global Investor Day, we unveiled our strategic plan and reiterated our balanced financial framework for value creation, including using our strong cash flows to deliver both growth investments and distributions to shareholders. We're confident in our plan and committed to continuing to deliver value for our shareholders, which is why today, in addition to reporting our outstanding 2021 results and a strong 2022 outlook, we're pleased to announce an 8% increase in our quarterly dividend. We're proud of our record of more than 40 years of annual dividend growth, and excited about our future," said Chairman and CEO Juan Luciano. The dividend is payable on March 1, 2022, to shareholders of record on Feb. 8, 2022. As of Dec. 31, 2021, there were 559,551,590 shares of ADM common stock outstanding.
|
AJRD LMT | Hot Stocks10:45 EST Aerojet Rocketdyne drops 15% to $38.19 after FTC sues to block takeover
|
AJRD LMT | Hot Stocks10:44 EST FTC sues to block Aerojet Rocketdyne buyout by Lockheed Martin - The Federal Trade Commission sued to block Lockheed Martin (LMT) proposed vertical acquisition of Aerojet Rocketdyne (AJRD). Aerojet supplies advanced power, propulsion, and armament systems, "which are critical components for the missiles made by Lockheed and other defense prime contractors," the FTC said in a statement. The agency's complaint alleges that if the deal is allowed to proceed, Lockheed will use its control of Aerojet "to harm rival defense contractors and further consolidate multiple markets critical to national security and defense." Lockheed's proposed acquisition of Aerojet would give Lockheed control over critical propulsion inputs that its rivals require to compete against Lockheed, the FTC says. The U.S. government in turn would be harmed because the cost of missile systems, missile defense kill vehicles, and hypersonic cruise missiles would likely increase, innovation would be lessened, and quality would be reduced, hindering national security and defense interests, according to the agency. Reference Link
|
LMT AJRD | Hot Stocks10:41 EST FTC sues to block Lockheed Martin acquisition of Aerojet Rocketdyne
|
IVZ | Hot Stocks10:18 EST Invesco plans to repurchase up to $200M in common stock in Q1 - Earlier, along with its report of Q4 results, Invesco stated that the company did not purchase any of its shares in the open market during 2021. The company also announced a plan to repurchase up to $200M in common stock in the first quarter of 2022, subject to market conditions. President and CEO Marty Flanagan said, "In addition, our financial strength, including strong revenue growth, underpinned by expense discipline, generated positive operating leverage and meaningful operating margin improvement. This has allowed us to continue to make key investments in our business while creating efficiencies that will help us continue to deliver a high level of value to clients. We remain focused on building a strong balance sheet and creating greater financial flexibility. As a result, we are pleased to announce our intention to buy back $200 million in common shares during the first quarter."
|
IMMX... | Hot Stocks10:17 EST Immix: IMX-110 + anti-PD-1 combination produced 63-day median survival in trial - Immix Biopharma (IMMX) announced data showing that IMX-110 + anti-PD-1 produced 63-day median survival in a genetic pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have an intact immune system. "This data highlights why we are excited to collaborate with BeiGene on our planned 2022 Phase 1b/2a combination clinical trial of IMX-110 + BeiGene anti-PD-1 tislelizumab in advanced solid tumors," said Ilya Rachman, MD PhD, CEO of ImmixBio. "We believe this upcoming combination clinical trial will allow us to rapidly expand into multiple oncology indications." The U.S. FDA has approved orphan drug designation for IMX-110 for the treatment of soft tissue sarcoma. Additionally, the FDA has approved rare pediatric disease designation to IMX-110 for the treatment of a life-threatening pediatric cancer in children, rhabdomyosarcoma. In January 2021, BeiGene (BGNE) and Novartis (NVS) entered into a collaboration and license agreement granting Novartis rights to develop, manufacture, and commercialize anti-PD-1 tislelizumab in North America, Europe, and Japan in exchange for an upfront payment by Novartis of $650M plus royalties and milestone payments.
|
MMM | Hot Stocks10:12 EST 3M: Nothing has changed with regard to buyback strategy
|
WE | Hot Stocks10:04 EST WeWork, Second Front partner for secure software development infrastructure - WeWork and Second Front Systems have partnered to provide government agencies secure software development capabilities in support of U.S. national security. Through this collaboration, federal government WeWork members will have access to a complete, fully secure continuous integration and continuous delivery platform available with their membership bundle or by adding an additional feature.
|
MMM | Hot Stocks10:02 EST 3M still releasing PFAS chemical at certain locations, CEO Michael Roman says - Comments taken from Q4 earnings conference call.
|
VIAO | Hot Stocks10:00 EST VIA Optronics falls -8.3% - VIA Optronics is down -8.3%, or -70c to $7.75.
|
CRK | Hot Stocks10:00 EST Comstock Resources falls -10.6% - Comstock Resources is down -10.6%, or -83c to $7.02.
|
AJRD | Hot Stocks10:00 EST Aerojet Rocketdyne falls -15.6% - Aerojet Rocketdyne is down -15.6%, or -$7.00 to $38.00.
|
EVTL | Hot Stocks10:00 EST Vertical Aerospace rises 10.9% - Vertical Aerospace is up 10.9%, or 82c to $8.34.
|
TRQ | Hot Stocks10:00 EST Turquoise Hill rises 15.3% - Turquoise Hill is up 15.3%, or $2.31 to $17.41.
|
BALY | Hot Stocks10:00 EST Bally's rises 24.5% - Bally's is up 24.5%, or $7.15 to $36.38.
|
JNJ | Hot Stocks09:57 EST Johnson & Johnson says constantly looking at M&A as 'key source of growth' - Says continues to look at smaller, tuck-in deals, but will also consider mid-size and larger acquisitions. Says has "no artificial ceiling" regarding deal size. Says looking to use cash in "disciplined and responsible way." Says offsetting inflation pressures with select price increases in portfolio.
|
PTC | Hot Stocks09:52 EST PTC, Schaeffler enter strategic alliance to accerate dgital transformation roadm - PTC and Schaeffler announced a new alliance that will see Schaeffler standardize on PTC solutions to deploy an integrated, end-to-end IT landscape. Schaeffler will also inform PTC's efforts to further develop and evolve market-specific standard solutions to better meet the needs of automotive and industrial companies. The new alliance will build on the successful twenty-year relationship based on Schaeffler's use of PTC's CAD and PLM solutions. These tools are essential for the introduction and further development of Schaeffler's initiatives for digital twins and for visualization of 3D models, for example those used for augmented reality projects. Schaeffler plans to leverage PTC's experience and robust end-to-end solutions to move from a customized engineering IT environment to using standard applications across the enterprise. This will enable prompt responses to rapidly changing requirements in a dynamic, competitive environment. The alliance will focus on the optimization of the existing environment, as well as its expansion with projects such as Schaeffler's Enterprise Traceability or Model-Based Enterprise and the deeper integration of software development tools. The goal is company-wide integration of the software and system development solutions. This also enables improvement in the mapping of critical systems engineering requirements, such as the fulfillment of varying country-specific safety regulations.
|
CRK | Hot Stocks09:47 EST Comstock Resources falls -8.8% - Comstock Resources is down -8.8%, or -69c to $7.16.
|
STG | Hot Stocks09:47 EST Sunlands Online falls -10.0% - Sunlands Online is down -10.0%, or -59c to $5.33.
|
AJRD | Hot Stocks09:47 EST Aerojet Rocketdyne falls -14.9% - Aerojet Rocketdyne is down -14.9%, or -$6.72 to $38.28.
|
SOXS | Hot Stocks09:47 EST Direxion Daily Semiconductor Bear 3X Shares rises 8.4% - Direxion Daily Semiconductor Bear 3X Shares is up 8.4%, or 40c to $5.12.
|
TRQ | Hot Stocks09:47 EST Turquoise Hill rises 17.6% - Turquoise Hill is up 17.6%, or $2.66 to $17.76.
|
BALY | Hot Stocks09:47 EST Bally's rises 23.8% - Bally's is up 23.8%, or $6.97 to $36.20.
|
ELYS | Hot Stocks09:42 EST Elys reports binding term sheet with Lottomatica S.p.A. for sportsbook platform - Elys Game Technology announced a binding term sheet with Lottomatica S.p.A. that outlines the entry into a definitive agreement and ancillary agreements to design, develop and service a customized sportsbook technology platform focused on Lottomatica's North American growth initiatives. Michele Ciavarella, Executive Chairman of Elys Game Technology, said, "This partnership adds a new evolution for Elys' innovative sportsbook technology and is yet another example of our modular architecture's ability to seamlessly integrate. We look forward to working closely with Lottomatica and their commercial partners to provide a competitive, flexible, and effective technology solution throughout this long-term relationship. We believe that this partnership could also foster significant synergies in the online gaming industry, both domestically and internationally, and is positioned to drive long-term shareholder value for both companies."
|
FE BP | Hot Stocks09:41 EST FirstEnergy appoints Steve Fortune as VP, CIO - FirstEnergy (FE) announced that Steve Fortune has been named vice president and chief information officer, effective February 7. Fortune will be responsible for leading FirstEnergy's Information Technology organization, including the Cyber and Physical Security, Innovation and Digital Enablement and Information Technology groups. Under his guidance, the IT organization will play a significant and critical role in FirstEnergy's mission to digitally transform the company and achieve productivity improvements through system integration and advanced technology. Fortune will report to Sam Belcher, senior vice president, Operations. Fortune joins FirstEnergy after more than 30 years with BP (BP), ranked 18th on the Fortune Global 500, where he began his career as a chemical engineer.
|
ADAG | Hot Stocks09:40 EST Adagene Inc (ADS) trading resumes
|
ADSE | Hot Stocks09:35 EST European Sustainable Growth Acq Corp trading resumes
|
ADSE | Hot Stocks09:30 EST European Sustainable Growth Acq Corp trading halted, volatility trading pause
|
ADAG | Hot Stocks09:30 EST Adagene Inc (ADS) trading halted, volatility trading pause
|
MITC | Hot Stocks09:28 EST MeaTech 3D appoints Arik Kaufman as CEO - MeaTech 3D announced the following changes to its executive management team and Board of Directors: Sharon Fima announced that, in light of the Company's current stage of development, he intends to step down from the positions of CEO, Chief Technology Officer and Director in the near future. Fima intends to continue supporting the Company as a founding member of the Company's scientific advisory board. MeaTech's Board of Directors appointed Arik Kaufman to the position of CEO, effective upon Fima's departure. Kaufman has founded various Nasdaq- and TASE-traded foodtech companies, and currently serves as director of Wilk Technologies. He is also a founding partner of the BlueSoundWaves collective. Kaufman holds extensive personal experience in the fields of food-tech and bio-tech law, and has led and managed numerous complex commercial negotiations, as part of local and international fundraising, M&A transactions and licensing agreements. Steven H. Lavin and Danny Ayalon stepped down from MeaTech's Board of Directors effective January 24 in light of the Company's current stage of development and to pursue other ventures, and both outgoing directors expressed their ongoing support for MeaTech and its technologies. In addition, Omri Schanin stepped down from the Board of Directors and continues to serve as MeaTech's Deputy CEO. Yaron Kaiser was appointed to the Board of Directors of the Company as its Chairperson.
|
JNJ | Hot Stocks09:21 EST Johnson & Johnson says continues to invest in R&D at 'competitive levels' - Says at lowest level of net debt in past five years. Says preferred option for M&A is "tuck-in" deals. Says "modest share repurchases" may be considered in capital allocation strategy. Says instituting price increases in Consumer Health unit in 2022. Sees above market growth for Pharmaceutical unit in FY22. Sees 2H22 better than 1H in Medical Devices segment. Sees approximately 50 bps improvement in FY22 adjusted pre-tax operating margin. Says "deeply optimistic" about future. Comments taken from Q4 earnings conference call.
|
STXS | Hot Stocks09:13 EST Stereotaxis announces HonorHealth robotic program offers Genesis RMN system - Stereotaxis announces that HonorHealth has established a robotic electrophysiology program as part of its Cardiovascular Center of Excellence at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona. HonorHealth is among the first in the nation to offer the Genesis Robotic Magnetic Navigation, RMN, system to patients receiving minimally invasive cardiac ablation procedures. "We are delighted to work with HonorHealth" said David Fischel, chairman and CEO of Stereotaxis. "We applaud their leadership and look forward to supporting their efforts to improve patient care, advance clinical science, and build a preeminent heart rhythm program."
|
VZ | Hot Stocks09:12 EST Verizon sees FY22 adjusted effective tax rate 23%-25% - Says 74% of customers subscribed to Unlimited plan. Says purchased 161MHZ of C-Band. Says experienced best Fios internet annual net adds since 2014. Says had 9M wireless postpaid device activations. Comments and guidance taken from Q4 earnings conference call.
|
PWSC | Hot Stocks09:12 EST PowerSchool to acquire Kinvolved, expanding K-12 platform - PowerSchool has signed a definitive agreement to acquire Kinvolved, a leading provider of K-12 communications, attendance, and engagement solutions supporting over 250,000 students and used within three of the top four school districts in the U.S. Adding Kinvolved's leading communication engine to PowerSchool's Unified Home solution will enable schools and districts to strengthen and simplify overall communications and notifications between school and home to increase engagement and help reduce absenteeism. "Collaboration between teachers, parents, and students is one of the most important aspects of an effective education, and we know it's a top priority for our customers to have efficient, centralized notifications and communications integrated with PowerSchool," said Hardeep Gulati, CEO of PowerSchool. "We look forward to welcoming Kinvolved to our PowerSchool team, and together making a bigger impact on improving student engagement and outcomes."
|
CMI | Hot Stocks09:11 EST Cummins names Mark Sifferlen chief risk officer - Cummins named Mark Sifferlen the company's first VP-chief risk officer and leader of environmental, social and governance strategy for the company, effective February 1. Since 2012, Sifferlen has served as the VP-ethics and compliance for Cummins.
|
STRC | Hot Stocks09:09 EST Sarcos Technology, Robotics meets development milestone for Guardian XT - Sarcos Technology and Robotics announced that the Company successfully completed assembly of the Beta version of the Guardian XT teleoperated dexterous mobile robotic avatar system at the end of 2021, as scheduled. The Guardian XT robot is an upper-body variant of the award-winning Sarcos Guardian XO full-body, battery-powered industrial exoskeleton. Sarcos is currently conducting internal Beta testing of the Guardian XT robotic avatar system and expects to deliver units to partners for additional testing in mid-2022. Sarcos expects to commence initial production of the first commercial units of the Guardian XT robot, which will incorporate learnings from the Beta tests, at the end of 2022. "We are extremely pleased with the progress we've made in the development of our Guardian XT robotic system," said Kiva Allgood, president and CEO, Sarcos. "We've made some notable improvements to the Beta version, and ultimately, we believe this robot will have a significant and positive impact on a variety of industries, enabling increased productivity while keeping the operator out of harm's way."
|
INMB | Hot Stocks09:08 EST INmune Bio announces research collaboration with University of Hong Kong - INmune Bio announced that the company has entered into a pre-clinical research collaboration with Chinese University of Hong Kong, CUHK, to evaluate INKmune -- the company's pseudokine NK cell priming platform -- in nasopharyngeal cancer, NPC, a type of head and neck cancer. The Strategic Partnership Award for Research Collaboration, which was granted by the CUHK Office of Academic Links, is between Prof. Michael Tong at CUHK and Prof. Mark Lowdell at University College London and Chief Scientific Officer of INMB. "Over 180,000 cases of NPC were diagnosed last year with 85% originating in Asia. Current treatments are quite poor, leading to high mortality rates. History of EBV infection and genetic polymorphisms drive the incidence of the disease," said RJ Tesi, INmune Bio's Chief Executive Officer. "This peer-reviewed grant and international collaboration targeting what has historically been a difficult to treat solid tumor validates the versatility of INKmune. We look forward to translating this work to the clinic in the near future." This grant award to CUHK will fund pre-clinical work that, if successful, will provide the scientific rationale for a formal clinical trial in NPC at UCL in the U.K., CUHK in Hong Kong, and at sites in the U.S.
|
SSBI | Hot Stocks09:07 EST Summit State Bank declares quarterly dividend of 12c per share - The Board of Directors declared a $0.12 per share quarterly dividend on January 24, 2022 to be paid on February 17, 2022 to shareholders of record on February 10, 2022. The Bank also issued a 10% stock dividend that was paid on November 4, 2021 to shareholders of record as of the close of business on October 29, 2021. The Bank issued 607,659 shares as a result of the stock dividend, increasing its total shares outstanding to 6,684,759. All prior period average share and earnings per share calculations disclosed in this press release have been retroactively adjusted to account for this stock split.
|
EA | Hot Stocks09:06 EST Electronic Arts, Lucasfilm Games announce new Star Wars titles in development - Electronic Arts and Lucasfilm Games are joining forces to continue delivering gaming experiences set within the Star Wars galaxy. Respawn Entertainment is leading the development and production of these new projects. Vince Zampella, group GM and founder of Respawn, will oversee this new phase of EA's relationship with Lucasfilm. Game Director Stig Asmussen and his team at the studio are already working on the next game in the action adventure Star Wars Jedi series, and are joined by two new teams working to deliver additional Star Wars gameplay experiences across multiple genres. The third title is a Star Wars strategy game developed through a production collaboration with the newly formed studio Bit Reactor. Respawn will produce the new Star Wars strategy game while Bit Reactor leads on the development of the title.
|
USIO | Hot Stocks09:06 EST Usio reports Q4 credit card dollars processed up 41% - Louis Hoch, President and Chief Executive Officer of Usio, said, "We ended the year with the strongest quarter in the history of the Company, with $2.9B in total dollars processed, a 215% increase compared to the total dollars processed in the fourth quarter of 2020. ACH growth was particularly impressive, with electronic check transaction volume more than doubling and electronic check dollars processed nearly tripling compared to the same quarter a year ago. Total dollars loaded on prepaid cards set a new quarterly record at $65 million, fueling a 205% increase in prepaid card transaction volume compared to the fourth quarter a year ago. And, both Credit Card dollars and transactions processed for the fourth quarter were up more than 40% compared to the same quarter last year. As a result of the increases in each of our segments, total dollars processed for the year of $9.5 billion also set a new company record, and were up 184% from fiscal 2020. We expect this strong transaction and dollars processed volume to result in record fourth quarter revenues."
|
IEA | Hot Stocks09:04 EST IEA announces strategic alliance with LOGISTEC USA - Infrastructure and Energy Alternatives announced a new strategic alliance with LOGISTEC USA, a subsidiary of LOGISTEC Corporation, a cargo handling and marine services provider with 25 port locations within the United States. IEA intends to leverage its proven engineering, procurement, and construction, EPC, solutions with LOGISTEC's cargo handling capabilities in support of new utility-scale offshore wind developments along the U.S. east coast. Both companies believe this non-exclusive business alliance will result in improved economies of scale and supply chain efficiencies over the long-term. "As a leading EPC company serving the domestic onshore wind industry, IEA is uniquely positioned to capitalize on a long-term trend toward increased investment in offshore wind development," stated JP Roehm, CEO of IEA. "We believe this alliance will allow for improved logistics, supply chain, and material handling capability along the East Coast corridor where LOGISTEC has a significant geographic presence, one well-suited to service planned offshore wind developments in the region."
|
VRNS | Hot Stocks09:04 EST Varonis announces Version 8.6 of the Varonis Data Security Platform - Varonis Systems announces Version 8.6 of the Varonis Data Security Platform. The enhancements include expanded data security for Microsoft 365 with at-a-glance tools to uncover exposed files and folders, new threat models to defend against ransomware, and automated labeling for sensitive files. The Varonis Data Security Platform helps organizations secure their critical information using automation to enforce Zero Trust, tackle privacy and compliance tasks, and detect modern attacks by putting data first. New capabilities in Version 8.6 help organizations protect sensitive data within Microsoft 365 by defending against external attacks and making it easy to discover and remediate overexposed information as companies collaborate in the cloud. Version 8.6 of the Varonis Data Security Platform delivers: Dashboards to visualize data exposure from shared links. Varonis reveals how sensitive files, folders, or sites in SharePoint Online and OneDrive are shared-whether with specific people, organization-wide, with external users, or even the entire internet-so you can promptly remove access and reduce your organization's blast radius. Threat models that detect and defend against ransomware and modern attacks. Protect your Microsoft 365 environments with new and updated threat models designed to detect active ransomware attacks and insider threats. Expanded remediation capabilities for SharePoint Online and OneDrive sites. IT admins can easily remove risky collaboration links and crack down on overshared information in SharePoint Online and OneDrive sites-no matter who 'owns' the site-and keep data safe. Automatic labeling and data protection. Enforce data security policies and adhere to relevant regulations with new automatic labeling that can apply Microsoft AIP labels to data in SharePoint and OneDrive based on Varonis' highly accurate classification policies.
|
TTEK | Hot Stocks09:04 EST Tetra Tech awarded $16.9M task order - Tetra Tech announced that it has been awarded a $16.9M task order to provide application development, modernization, and enhancement services and other technical support under its $169M, multiple-award technology support services contract with the U.S. Department of Labor, Bureau of Labor Statistics, or BLS. BLS is responsible for measuring labor market activity, working conditions, and price changes in the economy. Under this five-year task order, the Tetra Tech Federal IT Services Group will provide full lifecycle technology services, including artificial intelligence and agile software development, to support the BLS Office of Prices and Living Conditions and Office of Productivity and Technology in collecting, analyzing, and disseminating essential economic information to support public and private decision-making.
|
TAP KO | Hot Stocks09:03 EST Molson in pact with Coca-Cola to launch new brand inspired by Simply juices - Molson Coors Beverage (TAP) announced it has expanded its exclusive agreement with The Coca-Cola Company (KO) to develop and commercialize a brand of alcohol beverages inspired by the Simply juice brand. "The deal marks another milestone in the relationship between Molson Coors and The Coca-Cola Company, following a successful first year for Topo Chico Hard Seltzer," the companies said. "Over the past two years, we've seen success by shaking up existing categories with new brands that have clear, compelling points of difference, like Coca-Cola's Topo Chico Hard Seltzer, Vizzy Hard Seltzer and ZOA Energy Drink. Now, we have a huge opportunity to leverage the power of Simply - a brand known for real juice and big flavor - to disrupt the full-flavor alcohol segment in a way that's never been done before," added Michelle St. Jacques, Molson Coors' Chief Marketing Officer. "Simply Spiked Lemonade and the national expansion of Topo Chico Hard Seltzer mark the latest initiatives to aggressively grow Molson Coors' above premium portfolio as part of the company's revitalization plan. Molson Coors Beverage Company will produce, distribute and market Simply Spiked Lemonade as part of an agreement with The Coca-Cola Company," Molson Coors said.
|
ITPOF | Hot Stocks09:03 EST Intertape Polymer announces commitment to sustainability goals - Intertape Polymer Group announced the Company's comprehensive commitment to embrace sustainability, including its goals, as part of its four strategic pillars for the business. The goals are designed to address the key materiality measures that the business can impact, with measurable outcomes and clear timelines upon which to evaluate progress. The Company's core sustainability goals and commitments include: 75% of the products manufactured by IPG, by revenue, will be Cradle to Cradle Certified by 2025, 75% of packaging products manufactured by IPG, by revenue, will be recyclable, reusable, or compostable by 2025 and 100% by 2030, 50% of the energy used by IPG, at a minimum, will be renewable by 2030, IPG signed "The Climate Pledge", a commitment to be net carbon zero by 2040, joining more than 200 other companies that have committed to the program co-founded by Amazon and Global Optimism, The top 200 people leaders at IPG will complete training and a management development program centered on inclusivity and diversity, IPG's workforce will be reflective of the demographics in the communities in which it operates by 2030, IPG published its Sustainable Product Design and Development Vision Statement, publicly stating its commitment to developing safe, circular, and sustainable products, and IPG established a new committee of the Board of Directors, the Environmental, Social & Governance Committee, to govern its stakeholder sustainability activities and the Company also formalized its sustainability management structure by introducing a Vice-President, Sustainability position reporting directly into the Chief Financial Officer.
|
AGRI | Hot Stocks09:03 EST AgriFORCE appoints Sabet as Director of Marketing, Communications - AgriFORCE Growing Systems has appointed Denise Sabet to the key role of Director of Marketing & Communications, Mauro Pennella, President AgriFORCE Brands announced recently. Sabet will focus on leading the global marketing and communications efforts of AgriFORCE as the Company continues to expand its market reach around the world, driving the Company's integrated model and building the corporate portfolio of brands across multiple verticals.
|
AVDX | Hot Stocks09:01 EST AvidXchange announces integration with Sage 100 Contractor - AvidXchange announced the integration of Sage 100 Contractor with AvidPay through the TimberScan Titanium platform, providing a full purchase-to-pay solution to help streamline the accounts payable process for more professionals in the construction industry. This integration is available through AvidSuite for Construction, a portfolio of AP automation offerings for leading construction accounting systems, including Sage Intacct and Sage 300 CRE, that is purpose-built for those users. With AvidPay completing the AP process in TimberScan Titanium, contractors and project managers can increase efficiency with the ability to now match purchase orders, route invoices for approval and make more secure vendor payments through the AvidPay Network.
|
AIHS | Hot Stocks09:01 EST Senmiao Technology launches online ride-hailing platform for drivers in Shenyang - Senmiao Technology announced the launch of its proprietary online ride-hailing platform for drivers in Shenyang, China. Over 6,000 rides have been completed in Shenyang on Senmiao's online ride-hailing platform since the platform was launched on December 17. With the addition of Shenyang, Senmiao's platform is now available in 14 cities across China, including six cities in Sichuan Province and eight major cities in other provinces in China.
|
UG | Hot Stocks09:01 EST United-Guardian board announces review of strategic alternatives - United-Guardian announced that the Company's Board of Directors has launched a formal review process to explore strategic alternatives. The purpose of the review is to ensure that value is being maximized for shareholders and that the Company has sufficient scale and financial resources to take advantage of the growth opportunities available to the organization. These alternatives could include, among others, possible joint ventures, strategic partnerships or alliances, an outright sale of the Company, or other possible transactions. Ken Globus, President of United-Guardian, stated, "As United-Guardian and the global economy continue to emerge from the COVID-19 pandemic, it is imperative that we select the best path forward for the next chapter of United-Guardian's continued growth. Management and the Board of Directors are working to ensure that the Company is positioned to seize the numerous growth opportunities available to United-Guardian. The Company's long history, leading product portfolio, and established relationships with the leading brands within our markets provide a firm foundation for future expansion. Maximizing value for our shareholders, ensuring stability for our employees, and positioning United-Guardian for continued success into the future are our priorities during this review."
|
EBIX | Hot Stocks08:58 EST EbixCash Travel signs sales agreement with Malaysian, Saudi Arabian companies - EbixCash Private announced that the EbixCash Travel Division has signed strategic sales agreements with two reputed travel wholesalers, namely Malaysia based Universal Travel and Holidays and Saudi Arabia based Arjaa Travel & Tourism to distribute its Via.com travel products in these countries. Under the terms of the agreement with Universal, EbixCash's online travel portal Via.com, has appointed Universal as its Wholesale General Sales Agent in Malaysia to distribute its airline inventory to other agents in Malaysia, using the Via.com travel booking platform. The appointment makes it easier for Malaysian travel agents intending to purchase air tickets to buy directly now from Via.com as transactions will no longer have to go outside Malaysia to agents in China and other parts of Asia, which has been the usually the case in Malaysia. All these agents will now be able to purchase airline inventory directly from Universal Holidays and pay in local Malaysian currency, without incurring international transaction charges. Under the terms of the other agreement in the Kingdom of Saudi Arabia with Arjaa, EbixCash's online travel portal Via.com, has appointed Arjaa as its Wholesale General Sales Agent in Saudi Arabia to distribute its Flights, Hotels and Holidays inventory available on via.com to huge network of B2B agents of Saudi Arabia and the Middle East, using the Via.com travel booking platform.
|
GE | Hot Stocks08:57 EST GE shares drop 5% in premarket trading after Q4 revenue misses consensus
|
GE | Hot Stocks08:57 EST General Electric sees negative free cash flow for Q1
|
TAP | Hot Stocks08:56 EST Molson in pact with Coca-Cola to launch new brand inspired by Simply juices - Molson Coors Beverage Company (TAP) has expanded its exclusive agreement with The Coca-Cola Company (KO) to develop and commercialize a brand of full-flavor alcohol beverages inspired by the country's #1 chilled juice brand, Simply . The deal marks another milestone in the relationship between Molson Coors and The Coca-Cola Company, following a successful first year for Topo Chico Hard Se"Over the past two years, we've seen success by shaking up existing categories with new brands that have clear, compelling points of difference, like Coca-Cola's Topo Chico Hard Seltzer, Vizzy Hard Seltzer and ZOA Energy Drink," said Michelle St. Jacques, Molson Coors' Chief Marketing Officer. "Now, we have a huge opportunity to leverage the power of Simply - a brand known for real juice and big flavor - to disrupt the full-flavor alcohol segment in a way that's never been done before."
|
HEXO | Hot Stocks08:53 EST Hexo provides update on 'The Path Forward' strategy - HEXO provided an update on its previously announced strategic plan, "The Path Forward", designed to solidify HEXO's position as the number one cannabis company in Canada by recreational market share, with the goal of becoming the first amongst its peers to be cash flow positive from operations. HEXO is committed to providing its shareholders with updates as the Company executes the strategic plan. Today's announcement provides updates to one of the five strategic pillars: "Accelerate growth through organic market share gains". The company said, "Today, HEXO's subsidiary, Redecan, announced that it had entered the cannabis edibles category in Canada with a new gummy confection called Redebles. Redebles are a unique flavour-forward experience containing four gummies at 10 mg of THC per pack and sold at an MSRP of $5.95. The gummies are made with CO2 extracted cannabis distillate, vegan friendly and gluten free ingredients, and are sugar coated. Redecan is the brand leader across several cannabis product categories. Today's news marks the brand's entrance into edibles; the fastest growing cannabis category in Canada. HEXO hopes that Redecan's innovative, low-cost, and high-quality edible offering will disrupt the marketplace and quickly become an industry leader. HEXO is also pleased to announce that Redecan's best-selling products are now available for sale in additional Canadian provinces, including Nova Scotia, New Brunswick, and Manitoba. Redecan is now represented in nine provinces and territories. Today, HEXO's subsidiary Latitude launched additional innovative wellness products including a transdermal cream and a CBD-forward body lotion. HEXO's commitment to Latitude highlights the Company's focus on innovation and understanding of the sophisticated and maturing cannabis customer. Today, HEXO also launched additional new products including, Original Stash Vape, Super Sour Diesel, OS.ONE Durban Poison and Garlic Jelly pre-rolls and dried flower, and UP Cannabis 3.5g bags of Ultra Sour, Lemon Z and Gelato 29."
|
HQI | Hot Stocks08:50 EST HireQuest announces acquisition of Northbound Executive Search - HireQuest announced that it has entered into a definitive agreement to acquire Northbound Executive Search in New York, New York. Founded in 2010, Northbound provides executive placement and short-term consultant services primarily to blue chip clients in the financial services industry. The company generated over $15 M of revenue in 2021. "The acquisition of Northbound continues to build out HireQuest's offerings in the higher margin executive placement and short-term consultant segments," commented Rick Hermanns, HireQuest's President and Chief Executive Officer. "The company is a natural fit for our growing family of brands and we are excited that Northbound's founders, Rachel and Greg Feder, will be staying on to lead Northbound into its next chapter." Greg Feder, co-founder and Managing Partner of Northbound, commented, "With this partnership, Northbound will have the ability to draw from an organization that will help to fuel our next stage of growth."
|
CMTL ACTG | Hot Stocks08:49 EST Comtech board rejects Acacia Research proposal to acquire the company - Comtech (CMTL) announced that the company's board of directors has unanimously rejected the unsolicited proposal to acquire Comtech received from Acacia Research (ACTG) on October 29, 2021. The Comtech board of directors, including the recently appointed members, carefully evaluated the proposal in consultation with the board's independent advisors and determined that the proposal undervalues the company and is not in the best interests of Comtech's shareholders. The company said, "The Comtech Board's unanimous conclusion regarding the inadequacy of Acacia's proposal is based on the following key considerations: Comtech has made strategic investments in innovative technologies that position the Company to capitalize on large, long-term renewal cycles in the 911 public safety and satellite and space communication markets. Structural changes in these markets are expected to drive significant long-term growth driven by multi-year investment cycles that are well-aligned with Comtech's core capabilities, products, and services. Comtech is already beginning to see the long-term benefits of these investments and end market trends, which have created a number of large-scale opportunities being pursued by the Company. As such, the Company's Board and management remain highly confident in Comtech's long-term business outlook and believe the Company is well positioned to create significant value for its shareholders. Based on the foregoing considerations, among others, the Board unanimously determined that the non-binding Acacia proposal grossly undervalues the Company, does not reflect the transformational changes underway in the Company's end-markets and the significant inherent value in the Company's plan, and, thus, is not in the best interests of the Company and its shareholders."
|
JUPW | Hot Stocks08:48 EST Jupiter Wellness announces $5M share buyback program - Jupiter Wellness announced it its board of directors approved a $5.0M share buyback program which expires on June 30. Under the Share Buyback Program, shares of the Company's common stock may be repurchased periodically in open market or privately negotiated transactions. The actual timing, manner, number, and value of shares repurchased under the program will be determined by management at its discretion and will depend on a number of factors, including the market price of Jupiter Wellness' common stock, general market and economic conditions, applicable requirements, and other business considerations. The Share Buyback Program does not obligate the Company to acquire any particular amount of common stock, and the program may be suspended or discontinued at any time at the Company's discretion. Jupiter Wellness intends to complete share buyback transactions under the Share Buyback Program prior to the close of its proposed acquisition of Next Frontier Pharmaceuticals. "Our Share Buyback Program demonstrates our confidence in Jupiter Wellness' business, our pending acquisition of Next Frontier Pharmaceuticals, and the growth opportunities we see over the near and long term," said Brian John, Chief Executive Officer of Jupiter Wellness. "We believe our common stock is undervalued. Given our cash position, we believe the Share Buyback Program is an attractive use of capital as we reposition our Company as a pure play drug development company focused on cannabinoids."
|
CVLT | Hot Stocks08:47 EST Commvault says pipeline 'in good shape' so far in Q4
|
CAG | Hot Stocks08:47 EST Conagra Brands' Duncan Hines partners with Dolly Parton on new dessert line - Duncan Hines, a brand of Conagra Brands, is launching a new line of Southern-inspired desserts with international icon, Dolly Parton. This new line includes cake mixes and frostings inspired by some of Dolly's favorite family recipes like Coconut Cake and Banana Puddin' Cake.
|
CVLT | Hot Stocks08:47 EST Commvault sees Q4 EBIT margins 20%
|
XDSL | Hot Stocks08:46 EST mPhase Technologies Inc provides CEO letter, corporate update for 2022 - mPhase Technologies issued a letter to shareholders from its Chairman & CEO, Anshu Bhatnagar. "Valued Shareholders, By almost every measure, 2021 was an extraordinary year... We will be reporting our fiscal 2022 Q2 results in a few weeks, and shareholders will once again see that we are one of the few companies that did not cede any ground in terms of revenue or momentum during the worst of the pandemic... In 2021, we were one of the top performing stocks on OTC Markets, with a 52-week return of 339.2%, and this performance is even more remarkable given the steps we took to improve our business during the year... Based on this rapid improvement, we are starting 2022 with some compelling metrics...When we report our Q2 numbers next month, we expect to mark our 11th straight quarter of year-over-year revenue growth, a remarkable achievement, given the challenges of two years of global business disruption... Last year, we announced 3,265 mPower ecosystem sites in three states, but that is just the beginning... Our initial target is to layer our consumer engagement onto all sites, with EV charging in about 15% of locations. By this same time next year, we plan to have a multi-state footprint of more than 10,000 mPower locations... One of our primary goals in 2022 is to uplist to a listed exchange, so that remains a central theme in our strategic plan... EV+ is a term we hope to make synonymous with mPower, as we work to create a new kind of ecosystem for the EV-centric world that will be synonymous with travel and commerce by the end of this decade."
|
CMTL ACTG | Hot Stocks08:46 EST Comtech rejects unsolicited offer from Acacia Research
|
CVLT | Hot Stocks08:44 EST Commvault expects Metallic gross margins to improve over time - Comments taken from Q3 earnings conference call.
|
JYNT... | Hot Stocks08:44 EST Joint appoints Charles Nelles as Chief Technology Officer - The Joint (JYNT) appointed Charles Nelles into the newly-created position of Chief Technology Officer. Reporting directly to Peter D. Holt, President and CEO of The Joint, Nelles is tasked with driving technology innovation across the organization. Prior to The Joint, Nelles held the role of vice president of technology at American Express (AXP) Global Business Travel, where he was responsible for oversight of their global technology infrastructure and service delivery processes supporting corporate travel, expense management, meetings & events and global business consulting. Prior to joining American Express Global Business Travel, Charles worked as vice president of technology operations support and cloud enablement at Western Union (WU). In addition to financial services, Nelles has served in several healthcare organizations, such as The Children's Hospital of Denver and PacifiCare Health Systems, in various IT leadership capacities.
|
JSDA | Hot Stocks08:44 EST Jones Soda signs sponsorship deal with UFC Champion Julianna Pena - Jones Soda announced it has secured a sponsorship agreement with Julianna Pena, the mixed martial artist who won the UFC Women's Bantamweight Championship last month and was recently named MMA Junkie's Female Fighter of the Year.
|
DH | Hot Stocks08:43 EST Definitive Healthcare launches Latitude Discovery product - Definitive Healthcare announced the availability of Latitude Discovery, a new product aimed at pre-commercial biopharma and medical device companies. With Latitude Discovery, users can quickly perform iterative analysis of real-world data to assess and size potential market opportunities associated with therapy development for granular patient cohorts. Latitude Discovery is purposefully designed to meet the needs of pre-commercial pharmaceutical, biotechnology and medical device companies who are looking to bring new treatments to market. With billions of commercial medical claims, Latitude Discovery users gain self-service access to the precise market intelligence they need when they need it as they advance through the lengthy commercialization process. Key capabilities of Latitude Discovery include: The ability to quickly create new patient cohorts for analysis and reporting using any combination of diagnosis or procedure with additional filters on patients and providers; Rapid real-time commercial intelligence visualizations on the size of addressable patient and provider populations, clinical volumes, demographics and payor mix; Customizable claims data report templates to understand all additional diagnoses and procedures associated with the target population.
|
BTN AMC | Hot Stocks08:42 EST Strong/MDI Screen Systems signs screen supply agreement with AMC Theatres - STRONG/MDI Screen Systems (BTN) announced it has signed an exclusive cinema screen supply agreement with the largest theatrical exhibitor in the United States and the world, AMC Theatres (AMC) for its U.S.-based theatres.
|
YTEN BASFY | Hot Stocks08:42 EST Yield10 Bioscience hires Greenfield as Senior Director of Seed Operations - Yield10 Bioscience (YTEN) announced the hiring of Darren Greenfield to serve as the Company's Senior Director of Seed Operations. In this newly created position, Greenfield will be responsible for Camelina seed scale up and commercial contract production. He joins Yield10 from BASF Canada (BASFY).
|
OTMO AUDVF | Hot Stocks08:40 EST Otonomo Technologies, Audi AG partner for data-driven services - Otonomo Technologies (OTMO) announced AUDI AG (AUDVF) as a vehicle data platform partner. With access to rich, actionable vehicle data, Audi's customers and business partners can create consumer offerings that enhance the user experience for Audi vehicle owners, ranging from pay-as-you-drive and insurance services, to general vehicle status, to first notification of loss. The Otonomo mobility intelligence platform cleanses, harmonizes, and secures vehicle data and makes it readily accessible through Otonomo's straightforward API and user-friendly platform. Under the terms of the partnership, Audi will provide Otonomo with data points from Audi connected cars, ranging from odometer readings to crash information, including impact location and severity. At launch, Audi and Otonomo will start with a couple of dozens of data points, spanning use cases such as: Pay-as-you-drive: This data can be used for usage-based insurance and includes data elements such as mileage readings and parking time. First Notification of Loss: This use case is of interest to insurance companies and contains information about accident events, the severity of the accident and the location of the impact. Vehicle Status: This includes, among other things, the status of doors or a sliding roof.
|
STEM | Hot Stocks08:40 EST Stem awarded energy storage portfolio by NineDot Energy - Stem announced the Company has entered into an agreement to provide smart energy storage services to NineDot Energy, a cleantech developer that designs and deploys community distributed energy generation and storage projects. The projects consist of six front-of-the-meter standalone energy storage sites in Staten Island that represent more than 110 megawatt hours . The portfolio, expected to be completed by May 2023, will participate in New York's Value of Distributed Energy Resources program, through which NineDot will develop the energy storage sites, own the assets, and monetize the VDER credits. In addition to procuring the storage hardware, Stem will use its Athena smart energy software to optimize VDER credits and other incentive programs to help generate additional project revenues, achieve incentive and warranty compliance, and provide a single platform for NineDot to monitor the portfolio of energy storage sites.
|
PANW | Hot Stocks08:40 EST Palo Alto Networks selected by the Department of Veterans Affairs - Palo Alto Networks announced that the Department of Veterans Affairs, or VA, selected Palo Alto Networks to secure its expanded remote workforce, its network of Internet of Medical Things "IoMTs" and the new Electronic Health Record Modernization, or EHRM program. The VA will adopt industry-leading Palo Alto Networks products in this multiyear agreement, supporting the VA's efforts to deliver seamless, secure services to U.S. veterans.
|
TLS ORCL | Hot Stocks08:39 EST Telos' enterprise cyber risk management platform selected by Oracle - Telos (TLS) announced that Oracle (ORCL) has selected Telos' enterprise cyber risk management and compliance analytics platform Xacta for management and automation of security compliance at multiple classification levels. The most recent update of Xacta includes machine-readable data exchange capabilities for risk management automation and efficiency through the integration of the Intelligence Community's BoE.xml standard, the development of our own Xacta Data Exchange standard, and the early integration of NIST's Open Security Control Assessment Language.
|
FFIC... | Hot Stocks08:38 EST Flushing Financial partners with NYDIG to offer bitcoin servicees - Flushing Financial announced it has entered into an agreement with NYDIG to offer bitcoin services to its customers. The bank plans to launch this service in the first quarter of 2022 and will post additional information on its company website.
|
ANIX | Hot Stocks08:38 EST Cleveland clinic receives patent in Japan for ovarian cancer vaccine - Anixa Biosciences announced that the Japanese Patent Office has issued a Decision to Grant of a patent to Cleveland Clinic titled, "Ovarian Cancer Vaccines." The technology was invented by Drs. Vincent K. Tuohy, Suparna Mazumder and Justin M. Johnson at Cleveland Clinic. Anixa is the worldwide licensee for the vaccine technology. Patents for the technology were issued in the U.S. and Europe in 2021. "We're pleased to announce this additional intellectual property protection of Anixa's novel ovarian cancer vaccine, which was developed at Cleveland Clinic and is being studied at NCI. This unique technology has the potential to be the first vaccine to prevent ovarian cancer, which remains one of the most devastating and difficult-to-treat cancers," said Dr. Amit Kumar, CEO, President and Chairman of Anixa Biosciences. The ovarian cancer vaccine targets the extracellular domain of anti-Mullerian hormone receptor 2, which is expressed in the ovaries but disappears as a woman reaches and advances through menopause. Of note, the majority of ovarian cancer diagnoses occur after menopause, and AMHR2-ED is expressed again in the majority of ovarian cancers. By receiving a vaccine such as Anixa's that targets AMHR2-ED after reaching menopause, ovarian cancer, historically one of the most aggressive gynecological cancers, could be prevented from ever developing.
|
BMEA | Hot Stocks08:38 EST Biomea Fusion doses first patient in Phase I trial of BMF-219 - Biomea Fusion announced that the first patient has been dosed in its Phase I clinical trial evaluating BMF-219, the company's irreversible covalent menin inhibitor, in patients with relapsed/refractory acute leukemias, including those with MLL1/KMT2A gene rearrangements or NPM1 mutations. "We are honored and deeply humbled by this significant milestone, which marks our successful transition to a clinical stage company. Just over four years ago, we took the concept of designing a small molecule that targets menin and brought forward BMF-219 to the clinic to significantly improve the lives of patients," said Thomas Butler, Biomea's CEO and Chairman of the Board. "I'm incredibly proud of our team for their ability to execute on this aggressive timeline. This signals how we intend to operate as a drug discovery and development organization - advancing world-class science with rapid momentum and driven by an unwavering mission to improve patient outcomes and save lives. We are pursuing a novel approach to developing best-in-class molecules with our FUSION System across multiple indications and anticipate announcing our next pipeline candidate in the first half of 2022."
|
LMT | Hot Stocks08:37 EST Lockheed Martin sees FY22 Aeronautics sales $27.3B, Space sales $11.15B - Sees FY22 MFC sales $11.3B, RMS sales $16.25B. Sees FY Aeronautics segment operating profit $2.87B, Space operating profit $1.03B, RMS operating profit $1.66B, MFC operating profit $1.615B.
|
MMNFF | Hot Stocks08:37 EST MedMen appoints Tyson Rossi as chief strategy officer - MedMen announced the appointment of Tyson Rossi to the role of chief strategy officer. Rossi has been a member of MedMen's executive management team since 2019, most recently serving as senior VP, product and revenue. He is a retail and cannabis industry veteran, with over 25 years of experience in global brand strategy and vertical cannabis operations, including over a decade of experience in the legal cannabis space.
|
EMKR | Hot Stocks08:37 EST Emcore awarded continuing development contract for IMU for ATP - EMCORE announced that it has been awarded a continuing development contract by a major U.S. prime contractor to finalize the design and establish low-rate initial production processes to manufacture high-end Inertial Measurement Units, IMU, for Advanced Tactical Pods, ATP. For this contract, EMCORE expects to deliver initial production units that will be used for proof of manufacturing and system level qualification beginning in 2022. This contract follows the $1.1M contract awarded to EMCORE in 2021 for the continued advancement of the customer's ATP program enabling them to demonstrate increased capabilities in support of their strategic rollout and growth initiatives for ATP.
|
GPC | Hot Stocks08:36 EST Genuine Parts appoints Bert Nappier as CFO - Genuine Parts announced that Carol Yancey, Executive Vice President and CFO, has informed the Board of Directors of her plan to retire at the end of May 2022, after a distinguished 30-year career with the Company. The Company also announced that Bert Nappier will join as Executive Vice President and CFO-Elect, effective February 28. Nappier will assume the role of CFO on May 2, and Yancey will serve in an advisory role until her retirement to assist in an orderly and seamless transition. Nappier will have responsibility for GPC's global financial operations and will play a key role in advancing the Company's strategic initiatives. He will report to Paul Donahue, Chairman and CEO. Nappier will join GPC with a diverse background spanning nearly 25 years, including the last 16 years with FedEx Corporation. Since June 2020, he served as Executive Vice President, Finance and Treasurer, where he led teams responsible for corporate finance, cash management, global tax planning and strategy, risk management and corporate development.
|
LMT | Hot Stocks08:36 EST Lockheed Martin: 2022 outlook consistent with October trending - Comments taken from Q4 earnings conference call presentation slides.
|
ORIC | Hot Stocks08:36 EST Oric Pharmaceuticals announces regulatory clearance for OTIC-114 CTA - ORIC Pharmaceuticals announced clearance of its Clinical Trial Application by the regulatory authorities of the Republic of Korea for ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations. "This marks our third IND/CTA regulatory clearance in the last eight months and further demonstrates the productivity and commitment of our team as we expand our clinical portfolio to advance our mission on behalf of patients," said Jacob Chacko, M.D., president and CEO. "We are encouraged by the brain penetrant properties and selectivity that ORIC-114 has demonstrated in preclinical studies, and we look forward to advancing the program into a Phase 1 study in the coming months. As we enter 2022, we are well positioned with five expected clinical updates across four clinical programs through the first half of 2023, and with cash and investments to fund our operating plan into the first half of 2024."
|
IQ | Hot Stocks08:35 EST iQIYI announces CFO Xiaodong Wang retires, Jun Wang to succeed - iQIYI announced that Xiaodong Wang has retired from his position as CFO, effective January 25, due to personal reasons. The company has appointed Jun Wang to succeed Xiaodong Wang as the new CFO. Xiaodong Wang will continue on as an advisor to iQIYI to ensure a smooth transition, through April 30.
|
IMVT | Hot Stocks08:35 EST Immunovant appoints Mark Levine as Chief Legal Officer - Immunovant announced the appointment of Mark Levine as Chief Legal Officer. Levine joins Immunovant with more than 20 years of legal experience. Levine most recently served as General Counsel and Corporate Secretary of Flexion Therapeutics.
|
KSS | Hot Stocks08:35 EST Macellum Advisors sends open letter to Kohl's board of directors - Macellum Advisors, a long-term holder of nearly 5% of the outstanding common shares of Kohl's, issued an open letter to the company's board of directors. The letter said, "As you know, Macellum is a nearly 5% shareholder of Kohl's and has spent multiple years trying to engage with the Company to catalyze enhanced value creation. The public letter we issued last week encouraged the Board to initiate a comprehensive review of strategic alternatives, including a potential sale of Kohl's to one of the many well-capitalized financial sponsors that we believed were - and remain - interested in acquiring the Company. Despite another year of stagnation and more than two decades of underperformance at Kohl's, the Board quickly responded to us with a dismissive press release that referred to our assessment of potential suitors as "unfounded speculation."1 Now, less than one week later, the Board has validated our assessment by confirming expressions of interest after a $64 per share all-cash offer from Acacia Research Corporation and a reported approach from Sycamore Partners. While the Board boasted last week that "Kohl's strategy is producing results," the market's extremely positive reaction to the expressions of interest confirmed this morning indicates to us that investors want an organized sales process.2 Multiple sell-side analysts also issued notes yesterday that acknowledge the superior value that can likely be obtained via a sale. In our view, the Board cannot ignore yesterday's approximately 35% spike in the Company's share price and try to chill acquirers' interest. Rather than cling to the status quo, we urge the Board to immediately take the following steps to try to maximize value for all shareholders: Publicly commit to carrying out a robust process to review strategic alternatives; Form a special committee of independent directors to oversee the review, retain advisors and solicit proposals from all interested bidders, and; 3. Invite a Macellum representative to join the Board and lead the special committee, effectively providing credibility to the process. Though we believe Kohl's could be a source of significant value with a significantly refreshed Board, improved execution and an optimized balance sheet, we feel the best risk-adjusted path forward for shareholders right now is a credible and open process to evaluate a full sale of the Company at an attractive premium. We are eager to lend our expertise and support this process if the Board will extend us an invitation without onerous conditions and terms. Candidly, we do not have faith in the current Board to run this process on its own, nor do we believe the Board is capable of objectively evaluating possible bids relative to its historically overly optimistic assessments of management's standalone plans. In the interest of transparency, we are making this correspondence public. We hope the Board responds to us in a constructive and timely manner. However, we reserve our right to hold the current directors accountable through an election contest or the appropriate legal channels if the Board chills a value-maximizing sales process."
|
IMMP | Hot Stocks08:33 EST Immutep estimates cash reach into December 2023 - The Company's cash and cash equivalent balance as at 31 December 2021 was $99.66M compared to a balance of $106.39M as at 30 September 2021. Immutep's cash balance puts the company in a "strong financial position" with an estimated cash reach of December 2023.
|
UBER | Hot Stocks08:33 EST Uber partners with Smart & Final to expand West Coast grocery offering - Uber Technologies announced its new partnership with Smart & Final Stores to expand their on-demand and scheduled grocery delivery to customers across the West Coast. Currently, 173 Smart & Final stores across Arizona, California and Nevada are available to shop through Uber and Uber Eats, with plans to onboard all of Smart & Final's 254 locations. Smart & Final is the first major grocery US partner to offer alcohol to customers through Uber Eats. Alcohol is now available for delivery in California with plans to expand the offering to Arizona and Nevada later this year.
|
MCHP | Hot Stocks08:32 EST Microchip announces 28V-input SA50-28 products - Space system designers cannot easily support non-standard voltages or add functions with traditional hybrid-style power converters. Microchip Technology has eliminated the cost, complexity and customization challenges of these hybrid solutions by offering a discrete-component-based, space-grade DC-DC power converter family that now includes 28V-input, 50-watt radiation-tolerant options. "Our latest 28V-input SA50-28 products greatly simplify and accelerate system development," said Leon Gross, vice president of Microchip's discrete product business unit. "They are easier to customize than alternative space-grade power converters so they can meet specific voltage, current and other needs. Customers gain flexibility while reducing the size, cost and complexity of their space system designs."
|
IMMP | Hot Stocks08:32 EST Immutep provides update on quarterly activities - Immutep provides an update on the ongoing development of its product candidates, eftilagimod alpha and IMP761 for the quarter ended 31 December 2021. Efti Development Program for Cancer: AIPAC - Phase IIb clinical trial - final data: The final results have given Immutep additional confidence efti can deliver a meaningful clinical improvement for diverse sets of cancer patients, as the Company started its preparations for a larger clinical trial in MBC via its Phase III clinical trial, AIPAC-003. AIPAC-003 - planned Phase III trial : In October 2021, Immutep received positive feedback from the European Medicines Agency regarding its clinical development program for efti. Immutep has also been interacting with the US FDA and is providing additional information relating to efti's unique mechanism of action as an agonist that leads to T cell expansion and proliferation. TACTI-003 - Phase IIb clinical trial: During the quarter, Immutep continued recruitment of patients for the TACTI-003 clinical trial. The study is in its start-up phase and additional sites are planned to be initiated in the first quarter of 2022. TACTI-002 - Phase II clinical trial: Immutep also reported data from the 2nd line HNSCC patients of TACTI-002 at the SITC 2021 conference. A total of 189 patients are now participating in TACTI-002 across Parts A, B, and C at approximately 20 clinical sites in Australia, Europe, and the US. Additional data from TACTI-002, particularly in NSCLC, are planned to be reported in the first half of calendar year 2022. INSIGHT: INSIGHT is an investigator-initiated Phase I trial at the Institute of Clinical Cancer Research, Krankenhaus Nordwest investigating different combination treatments with efti and a different route of administration for efti. INSIGHT-003 - triple combination: In December 2021, the first five patients were enrolled and safely treated in the INSIGHT-003 study, also referred to as stratum C of INSIGHT. Patient recruitment is ongoing with 6 out of a total of 20 patients with various solid tumours now participating in the trial. Interim results are expected to be reported in 2022. INSIGHT-005 - combination with bintrafusp alpha: INSIGHT-005, known as stratum E of INSIGHT, will include 12 patients with solid tumours and will evaluate efti in combination with bintrafusp alfa. EAT COVID - Phase II clinical trial - ongoing: The investigator-initiated EAT COVID study is continuing at the University Hospital Pilsen in the Czech Republic. Immutep will provide an update on the trial in due course. IMP761 Development Program for Autoimmune Disease: During the quarter, Immutep appointed Northway Biotech to manufacture IMP761 ahead of clinical testing.
|
BBKCF | Hot Stocks08:31 EST Bigg Digital Assets partners with ERUdyne to offer CCI course - BIGG Digital Assets announces a partnership with ERUdyne, a training and consulting firm, to offer the Certified Cryptocurrency Investigator course to U.S. Army personnel. The CCI credential is now listed in Army Credentialing Opportunities On-Line and approved for funding through the U.S. Army Credentialing Assistance Program. The CCI is an online training program, developed by a digital asset and dark web government investigator and an expert in financial compliance. The course is for law enforcement, intelligence analysts, legal, accounting, anti-money laundering specialists, and others combating financial crime through the illicit use of cryptocurrency. The CCI consists of five modules and includes topics on the basics of cryptocurrency, the origin of Bitcoin, the dark web, how criminals use cryptocurrency, and cryptocurrency forensics.
|
TRIB | Hot Stocks08:27 EST Trinity Biotech announces shareholders approve of all four resolutions at EGM - Trinity Biotech announced the results of an Extraordinary General Meeting, EGM. As previously announced, the Company has entered into refinancing transactions with respect to substantially all of the outstanding $99.9M of exchangeable senior notes issued by its subsidiary, Trinity Biotech Investment Limited, and guaranteed by the Company. At the EGM, the Company's shareholders approved all of the four resolutions put to the meeting, with each resolution being approved by at least 97% of votes cast.
|
GE | Hot Stocks08:27 EST GE: Offshore wind demand continues to significantly increase around the world
|
GBOX | Hot Stocks08:26 EST GreenBox POS 2021 processing volume grows to nearly $2B - GreenBox POS announced preliminary unaudited results for 2021 with a processing record of $1.95B in transaction volume, compared to $202M during the previous year. This represents a staggering increase of over 800% in processing volume, leading to revenues of at least $26M, an increase of over 200%, when compared to revenues of $8.5M in 2020. The Company's advanced blockchain ledger-based payment solutions product offering, combined with an expanding ISO and respected partnership network, as well as its strategic acquisition strategy to leverage a broader scope, opened the floodgates for a breakout year. This has resulted in remarkable growth for GreenBox, to not only establish their footprint in the payments industry but poise the company for further expansion across a myriad of verticals in 2022.
|
XELA | Hot Stocks08:25 EST Exela Technologies renews long standing relationship with consulting firm - Exela Technologies announced a renewal of its services contract with a leading consulting firm. The renewal reaffirms a 20-year relationship. The total contract value is over $35M. Digital Mailroom, DMR, and Exela's Intelligent lockers are a component of the broader suite of solutions provided to the customer.
|
VECO | Hot Stocks08:24 EST Veeco says semiconductor supplier qualifies Wet Processing System for packaging - Veeco Instruments announced that a world leading semiconductor supplier has qualified Veeco's WaferStorm Wet Processing System for advanced packaging applications that will support next generation high bandwidth memory. The customer also operates Veeco's AP300 Lithography Systems for advanced packaging production used to meet demand for 5G system-on-a-chip, graphic processors and high-performance computing applications.
|
NUWE | Hot Stocks08:23 EST Nuwellis announce Category III CPT code for Nuwellis Aquadex Ultrafiltration - Nuwellis announced that the new and dedicated Category III Current Procedural Terminology, CPT, code, 0692T for Therapeutic Ultrafiltration, is now in effect. Healthcare providers can utilize this code when using Aquadex to deliver ultrafiltration to adult and pediatric patients. "Reimbursement is critical in hospital administration decision-making and can make a difference in whether patients have access to the treatment they need," said Nestor Jaramillo, Jr., President and CEO of Nuwellis. "Ultrafiltration provides a life-saving therapy and significantly improves quality of life and economic savings. The Category III CPT code will expand access for patients experiencing the burden of fluid overload."
|
HESM | Hot Stocks08:23 EST Hess Midstream Partners sees FY22 capital expenditures $235M - Sees FY22 adjusted EBITDA $970M-$1B. Sees FY22 free cash flow $615M-$645M. "We are poised for continued volume and Adjusted EBITDA growth after a strong finish to 2021. The tie-in of our newly expanded Tioga Gas Plant gives us the capacity to capture further volume growth and drive free cash flow, creating an opportunity to return additional capital to our shareholders," said John Gatling, president and COO of Hess Midstream. "We remain focused on operational and commercial execution to capture increasing gas volumes, which are expected to increase by more than 30% by 2024 relative to 2021 based on Hess' current nominations."
|
AMSC | Hot Stocks08:22 EST AMSC completes delivery of HTS-based system for US Navy - AMSC announced it has completed delivery of AMSC's high temperature superconductor, HTS,-based ship protection system to be deployed on the San Antonio class of amphibious transport dock ship USS Fort Lauderdale. This delivery is a milestone in AMSC's first of four ship protection system contracts for the San Antonio Class Amphibious ship platform. AMSC expects to support the Navy's insertion of SPS into LPD 28. USS Fort Lauderdale will be the 12th amphibious transport dock ship of the USS San Antonio-class. "The delivery of this system is a watershed moment for our Company and for superconductor technology. We have a culture of delivery and believe that the delivery of this system demonstrates momentum for our Company and for the naval industry to adopt change," said Daniel P. McGahn, President, CEO and Chairman AMSC. "We look forward to continuing to work with the U.S. Navy to deliver and install our HTS degaussing system on future San Antonio class ships as well as other potential vessels."
|
APA | Hot Stocks08:22 EST APA Corp. provides Q4 supplemental information - APA Corporation provided supplemental information regarding certain fourth-quarter 2021 financial and operational results.To further assist analysts with their fourth-quarter earnings models, the company is providing the following estimates: Estimated Average Realized Prices - 4Q21: United States; Oil bbl- $76.00; NGL bbl- $34.00; Natural Gas Mcf-$4.70. InternationaL; $80.00; $70.00; $5.40. Egypt tax barrels:24-25 MBoe/d; Realized loss on commodity derivatives: $38 million; Dry hole costs: $25-30 million. During the fourth-quarter 2021, the company repurchased approximately 31.8 million shares of APA common stock at an average price of $27.13 per share. The estimated weighted-average basic common shares for the period is 361 million, compared with 379 million for the third quarter 2021.
|
NVEE | Hot Stocks08:20 EST NV5 Global awarded contracts over $8M by Midwest utility - NV5 Global announced that it has been awarded contracts exceeding $8M by a Midwest electric utility to acquire lidar data and provide remote sensing analytics across the utility's entire distribution system to mitigate risk of vegetation-related outages. NV5's data and analytics will be used to define the utility's 2022 and 2023 forestry management requirements. "Trees and storms are the leading cause of electrical service interruption, and the use of geospatial data analytics in identifying risks that vegetation poses to utility safety and service reliability is essential," said Dickerson Wright, PE, Chairman and CEO of NV5. "NV5's advanced geospatial solutions help utilities identify vegetation encroachment, forecast operational costs, and mitigate service interruptions while continuing to contribute to safe and reliable electricity delivery for our client's customers."
|
KTOS | Hot Stocks08:18 EST Kratos Defense, Hypersonix sign agreement to develop, fly DART AE drone - Hypersonix Launch Systems and Kratos Defense & Security Solutions have signed an agreement to launch the DART AE multi-mission hypersonic drone technology demonstrator. In the Hypersonix Kratos Team's submission to the Australian Department of Industry, Science, Energy and Resources Modern Manufacturing Initiative, MMI, Grants Program 2, the Team is planning for a launch and initial demonstration flight of the DART AE Hypersonic Drone System in 2023. "Kratos brings to the team and proposed effort its extensive digital engineering capabilities and sounding rocket booster integration and launch experience. The Kratos booster system will accelerate the DART AE drone to a speed greater than Mach 5 and release the vehicle, ignition of the Drone scramjet engine will occur, and autonomous flight of DART AE will proceed along a programmed flight path to a predetermined landing location," the company said.
|
ARIZ | Hot Stocks08:18 EST BitFuFu to go public via merger with Arisz Acquisition - Finfront Holding Company, a fast-growing digital asset mining service and cloud-mining service provider, and Arisz Acquisition Corp. announced that they have entered into a definitive business combination agreement that will result in BitFuFu becoming a publicly listed company on NASDAQ under an anticipated ticker symbol "FUFU". The transaction values the company at a pro forma enterprise value of approximately $1.5B. The Transaction values the combined company at an implied fully diluted pro forma enterprise value of approximately $1.5B, representing a 4.6x 2022 projected revenue of approximately $330M, and 3.3x projected December 2022 annualized recurring revenue of approximately $465M. The Transaction is expected to provide more than $129M in net cash proceeds to BitFuFu at closing, after transaction expenses and assuming no redemptions of shares by ARIZ's existing public stockholders. Existing BitFuFu stockholders are retaining 100% of their equity in the combined company. The proceeds from the Transaction are expected to fund mining equipment purchases and infrastructure build-out as the company expands its leadership position in the industry. The BitFuFu and ARIZ Boards of Directors have unanimously approved the proposed merger, which is expected to be completed in the third quarter of 2022, subject to, among other things, regulatory approval, the approval by BitFuFu's and ARIZ's stockholders of the proposed merger and satisfaction or waiver of other customary closing conditions. BitFuFu's management team, led by its founder Leo Lu, will continue to run the company after the transaction.
|
APRN | Hot Stocks08:18 EST Blue Apron partners with Panasonic for convenient cooking alternatives - Blue Apron announced a strategic partnership with Panasonic Consumer Electronics Company, a global leader in developing innovative products and solutions. Through this collaboration, Blue Apron will offer customers convenient cooking options combining select recipes with fast and delicious techniques using the Panasonic 4-in-1 Multi-Oven. "We are excited to introduce Panasonic as one of our partners this year. Their passion for bringing convenient and delicious solutions to kitchens around the country is perfectly aligned with our plans to broaden variety and flexibility on our menu," said Dani Simpson, Blue Apron's Chief Marketing Officer. "We continue to look for ways to sustainably grow customer engagement and retention rates, and we believe this partnership is yet another piece that will help us do so."
|
SGRP | Hot Stocks08:16 EST SPAR Group announces partnership with Repsly - SPAR Group announced a global partnership with Repsly, a provider of field applications, analytics and insights. "Developing insights, leveraging data and applying technology are strategic parts of our business. As a result, we are always innovating and looking for companies that provide unique value to clients and our industry. Repsly is one of those extraordinary companies. We look forward to working with the Repsly team to leap-frog the market and drive value for our shareholders," said Mike Matacunas, SPAR Group, President and CEO.
|
ARCT | Hot Stocks08:16 EST Arcturus reports new data on ARCT-154 and ARCT-165 booster clinical trial - Arcturus Therapeutics announced new data from clinical development programs for ARCT-154 and ARCT-165, its investigational, next-generation, self-amplifying mRNA vaccine candidates targeting variants of concern. New data from the Phase 1/2 booster trial, sponsored by Arcturus and currently ongoing in U.S. and Singapore, demonstrated that ARCT-154 and ARCT-165, when administered in low doses at least five months following initial vaccination with Comirnaty, yielded robust increases of 54- and 47-fold, respectively, in neutralizing antibody responses against the Omicron variant. These findings provide additional data to recently updated results from the Phase 1/2 demonstrating robust neutralizing antibody responses against SARS-CoV-2 D614G strain as well as several variants of concern, and is expected to support the expansion of clinical development of the candidates to evaluate their potential as booster vaccines.
|
SBEV | Hot Stocks08:15 EST Splash Beverage Group's TapouT to be distributed through Arkansas - Splash Beverage Group announced that TapouT, its high-performance energy drink will be distributed through Arkansas-based Central Distributors. Central already distributes Splash's Copa and Pulpoloco brands. Central Distributors has been an Arkansas family-owned wholesale beverage distributor since 1935 and today services the entire state of Arkansas from a 350,000 square foot facility located in Little Rock.
|
ACHV | Hot Stocks08:14 EST Achieve Life Sciences announces initiation of Phase 3 ORCA-3 clinical trial - Achieve Life Sciences announced it has initiated screening of ORCA-3, the confirmatory Phase 3 trial required for registrational approval of cytisinicline in the United States. ORCA-3 will evaluate the efficacy and safety of 3 mg cytisinicline dosed 3 times daily compared to placebo in 750 adult smokers at 15 clinical sites. Similar to the first registrational Phase 3 ORCA-2 trial, ORCA-3 participants will be randomized to one of three study arms to evaluate cytisinicline administered for either 6 or 12 weeks, compared to placebo. The primary outcome measure of success in the ORCA-3 trial is biochemically verified continuous abstinence during the last four weeks of treatment in the 6 and 12-week cytisinicline treatment arms compared with placebo. Secondary outcome measures will be conducted to assess continued abstinence rates through 6 months from the start of study treatment.
|
REG | Hot Stocks08:14 EST Regency Centers issues 2021 TCFD Climate Change Risk Report - Regency Centers announced the release of its 2021 Task Force on Climate-Related Financial Disclosures report. The report, which supplements and updates the TCFD section in our most current Corporate Responsibility Report, reflects Regency's continued commitment to corporate responsibility best practices and transparency. In line with the TCFD's recently updated disclosure recommendations, the report summarizes climate-related risks and opportunities and their potential impacts on the Company's strategy and business. Regency actively plans and implements actions to assess and mitigate the potential effects of climate change on our business, and intends to continue to build upon and revise the results of its climate change risk analysis, including the introduction of site-specific analysis
|
GE | Hot Stocks08:13 EST GE: Selectivity, supply chain headwinds impacted revenue by 3-4 points each
|
CGRN | Hot Stocks08:13 EST Capstone Green Energy enters 4MW two-year rental contract - Capstone Green Energy announced that it has entered into a 4 megawatt, or MW, two-year, long-term rental contract with a new end-use customer in the cryptocurrency mining space. The new two-year contract represents another 4 MW of clean Energy as a Service (EaaS) rental systems, and continues Capstone Green Energy's expansion of its current long-term rental fleet to 21.1 MW by March 31.
|
OTLK FUJIY | Hot Stocks08:13 EST Outlook Therapeutics provides corporate update, business outlook - Outlook Therapeutics (OTLK) provided a business outlook for 2022. ONS-5010 / LYTENAVA: ONS-5010 / LYTENAVA is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration and other approved retinal diseases. With the registration clinical trials now completed, Outlook Therapeutics plans to submit a new BLA under the Public Health Service Act 351(a) regulatory pathway in the first quarter of calendar 2022. If the BLA is approved as anticipated in the first quarter of calendar 2023, it is expected to result in 12 years of marketing exclusivity for ONS-5010 as the first and only ophthalmic formulation of bevacizumab approved by the FDA to treat wet AMD. Upcoming Milestones: Planned submission of new BLA to the FDA in the first calendar quarter of 2022; Execution of the NORSE SEVEN study evaluating Outlook Therapeutic's vial delivery system versus a pre-filled syringe of ONS-5010; Ongoing pre-launch commercial planning underway in anticipation of potential ONS-5010 approval; and Continued progress on preparation for NORSE FOUR (BRVO) and NORSE FIVE AND SIX (DME) evaluating ONS-5010 for additional ophthalmic indications. Pre-Commercialization Planning Underway: In anticipation of potential FDA marketing approval in 2022 for ONS-5010, Outlook Therapeutics has begun commercial launch planning, including manufacturing with drug substance manufacturer FUJIFILM (FUJIY) Diosynth Biotechnologies and drug product manufacturer Aji Biopharma Services, distribution, sales force planning, physician and payor advisory board outreach, key opinion leader support and payor community engagement. Outlook Therapeutics has already commenced collaborative discussions with payors and the retina community. Outlook Therapeutics is also developing registration documents on a parallel path for approvals in Europe and expects to submit them shortly after completing the BLA submission. Outlook Therapeutics continues to explore potential strategic commercialization partners, such as Syntone Biopharma JV in China.
|
RNGTF | Hot Stocks08:12 EST Osisko Development to acquire Tintic Consolidated Metals - Osisko Development is pleased to announce that it has entered into definitive agreements with IG Tintic and Ruby Hollow to acquire 100% of Tintic Consolidated Metals. On completion of the Transaction, Osisko Development will acquire 100% ownership of the producing Trixie Mine, as well as mineral claims covering more than 17,000 acres in Central Utah's historic Tintic Mining District. Tintic's recent discovery of an ultra-high grade structure positions Trixie as one of the highest grade gold mines in the world. Ongoing exploration work has demonstrated significant potential for expansion and further discovery both at Trixie and over the broader land package. Transaction supports Osisko Development's path towards becoming a leading intermediate gold producer. Production from Trixie complements the near and medium-term development plans for the Cariboo and San Antonio projects. In the near term, the Company is proposing technical work at Trixie with the objective that it will justify further development, targeting an increase in production from approximately 20 koz Au p.a. to approximately 100 koz Au p.a. by 2024 through a low-capital intensity expansion. Trixie is one of the highest grade gold mines in the world. The newly-discovered T2 structure shows excellent continuity of high grades and appears to be increasing in thickness towards the upper contact with shale. More than 2,300 underground samples collected over a 215 m strike length with an average grade of 93 g/t Au and 135 g/t Ag. Gold production from underground mining and vat leach processing in 2021 was 14,709 ounces at an average head grade of 59 g/t. Over the past week, production from exploration and development mineralization, which is processed, via small-scale vat leaching at approximately 45 tons per day, was at blended grades between 1.2 oz/ton and 5.7 oz/ton Au with an average of 4.5 oz/ton Au. Clear path to meaningful expansion and operational improvements Low capital intensity expansion planned at Trixie, targeting an increase in throughput to 500 tpd by the end of 2024. Equipment and infrastructure in place for a straight-forward cut and fill underground operation having low environmental footprint. Opportunity to significantly improve recoveries through metallurgical test work and implementation of appropriate processing technologies. Significant exploration upside at Trixie. Gold mineralization remains open up and down dip and along strike. Ongoing exploration outside of the T2 structure will continue along the 5 km Trixie trend to North Lily trend. Exposure to extensive land package in prolific brownfields district 100% ownership of more than 17,000 acres of mining claims in Utah's second most productive mining district after Bingham Canyon. The T2 structure at Trixie represents a new style of mineralization and a key focus will be to explore with the objective of finding similar structures at other past producing mines in the district. A 2011 preliminary economic assessment published on the Burgin Ag-Pb-Zn project dated November 17, 2011, previously mined by Kennecott, and highlighted the possibility for an economic project. Over 20 brownfields targets within the wider land package, which include the historic Eureka Standard mine and North Lily prospects. Osisko Development also plans to undertake an exploration program around known polymetallic and copper porphyry targets within the land package. Fully permitted for current operations with infrastructure in place Existing fully-operational milling and mining facilities and equipment. Retaining experienced and qualified full time workforce. Grid power, year round paved road access, and sufficient access to water.. Ideally located in top-ranked mining jurisdiction. Utah is ranked in the top-15 mining jurisdictions globally by the Fraser Institute and is ranked as the sixth mining jurisdiction by the Fraser Institute's Policy Perception Index.. The Tintic property is located in active and well-controlled brownfields district. Close proximity to mining services and suppliers. Tintic is a joint venture owned as to 75% by IG Tintic and as to 25% by Chief Consolidated Mining Company. Ruby Hollow holds an indirect 25% interest in Tintic through its ownership, directly and indirectly, of approximately 83% of the stock of Chief. Pursuant to the terms of the Transaction, Osisko Development will acquire 100% of Tintic from the Vendors for aggregate payments at closing totaling approximately US$177 million, of which approximately US$54 million will be paid in cash. In addition to the payments at closing, the Company will pay to the Vendors: US$12.5 million in deferred payments a 2% NSR royalty, with a 50% buyback right in favour of Osisko Development exercisable within 5 years; and other contingent payments, rights and obligations. See "Transaction Details and Timing" for more details.
|
SPLK | Hot Stocks08:11 EST Splunk appoints Rolddy Leyva as chief diversity officer - Splunk announced the appointment of Rolddy Leyva to chief diversity officer. Reporting to Kristen Robinson, chief people officer, Leyva will lead worldwide diversity, equity and inclusion and employee experience for the data platform leader for security and observability.
|
WE | Hot Stocks08:11 EST WeWork to acquire flexible workspace provider Common Desk, no terms - We Work and Common Desk announced that the companies have signed a definitive agreement under which WeWork will acquire Common Desk, a premier flexible workspace provider based in Dallas, Texas. The transaction is WeWork's latest step in executing on a path towards cost-efficient, strategic growth. Founded in 2012, Common Desk has expanded its network to serve 4,000 customers at a total of 23 locations across 13 cities in Texas and North Carolina. Over the past decade, Common Desk has achieved disciplined growth through strategic management agreements with landlords that have enabled the company to perform at strong margins by minimizing capital expenditures. Within Common Desk's existing portfolio, 19 of 23 locations are operated under management agreements.
|
GE | Hot Stocks08:09 EST GE topline numbers pressured by persistent supply chain challenges, says CEO - Comments taken from Q4 earnings conference call.
|
BJ | Hot Stocks08:09 EST BJ's Wholesale to acquire four distribution centers from Burris Logistics - BJ's Wholesale announced that it has entered into an agreement to acquire the assets and operations of four distribution centers and the related private transportation fleet from partner Burris Logistics. The transaction will allow BJ's to insource its perishable supply chain. The terms of the transaction were not disclosed. Burris Logistics is a 90-year-old family business that provides temperature-controlled distribution and logistics services to clients across the United States. For decades, Burris Logistics has partnered with BJ's to support the daily supply chain operations for BJ's perishable business. The proposed acquisition includes four perishable goods distribution centers, the personnel of these facilities, the associated real property, and the capital assets necessary for operations. This acquisition, which has been unanimously approved by the boards of directors of both companies, is subject to regulatory approval and traditional closing processes and is expected to close in the second quarter of 2022.
|
OR RNGTF | Hot Stocks08:08 EST Osisko Gold to acquire metals stream on Trixie Mine - Osisko Gold Royalties (OR) is pleased to announce that its wholly-owned subsidiary, Osisko Bermuda Limited has signed a non-binding term sheet with Osisko Utah LLC, a wholly-owned subsidiary of Osisko Development Corp. (RNGTF), with respect to a $20-40 million metals stream to facilitate ODV's acquisition of the high-grade Trixie Mine, as well as mineral claims covering more than 17,000 acres in Central Utah's historic Tintic Mining District. ODV announced that it has agreed to acquire a 100% interest in the Trixie Mine and Tintic Property through the acquisition, directly and indirectly, of all of the shares in the capital of Tintic Consolidated Metals from IG Tintic LLC and Ruby Hollow. TINTIC HIGHLIGHTS: Trixie is one of the highest grade gold mines in the world; Exploration mining conducted in 2021 produced 14,709 ounces of gold at an average head grade of 59 g/t. The newly-discovered ultra-high grade T2 structure adjacent to existing underground infrastructure has returned average grades of 93 g/t Au and 135 g/t Ag from more than 2,300 samples collected over a 215m strike length. Proposed expansion and operational improvements: In the near term, ODV is proposing to complete technical work with the objective that it will justify further development at the Trixie Mine, targeting an increase in throughput to 500 tons per day by the end of 2024 which could increase production from approximately 20k ounces of gold per annum currently to approximately 100k ounces of gold per annum upon completion of the expansion. Significant exploration upside at Trixie: Gold mineralization remains open up and down dip and along strike. T2 structure shows excellent continuity of high grades and appears to be increasing in thickness towards the upper contact with shale. Exploration outside of the T2 structure planned along the 5 km Trixie trend. Exposure to extensive land package in prolific brownfields district. More than 17,000 acres of mining claims in Utah's second most productive mining district after Bingham Canyon. T2 structure at Trixie represents a new style of mineralization and future exploration efforts will be focused on finding similar structures at other past producing mines in the district. Other brownfields targets within the broader land package include the historic Burgin mine, Eureka Standard mine and North Lily prospects, as well as known polymetallic and copper porphyry targets. STREAM DETAILS Upfront Deposit: OBL will make an upfront cash payment to ODV totaling at least US$20 million and up to US$40 million ODV may elect to draw the Deposit in full or in part upon closing of the Acquisition Transaction, with the proceeds to be used to fund the upfront consideration for the Acquisition Transaction. Streamed Metal: Should ODV elect to draw the full Deposit amount, OBL will purchase 5.0% of all metals produced from the Project until 53,400 ounces of refined gold have been delivered. Thereafter, OBL will purchase 4.0% of all metals produced from the Project for the remaining life of mine. The Threshold Stream and Tail Stream shall be reduced pro rata should ODV elect to draw less than the full Deposit amount. Production Payments: OBL will make ongoing payments for refined metal delivered to the Stream equal to 25% of the spot prices on the day prior to the date of delivery. Security: The Stream shall be a senior secured, first ranking obligation of ODV, inclusive of guarantees. Area of Interest: The Stream shall be referenced to production from the entire Tintic Property, including the Trixie mine. Closing: The Stream is expected to close concurrently with the closing of the Acquisition Transaction, subject to certain conditions precedent to closing, including, but not limited to, execution of all definitive agreements with respect to the Stream and the Acquisition Transaction.
|
KRNT | Hot Stocks08:08 EST Kornit Digital enters definitive agreement to acquire Tesoma - Kornit Digital announced that it has entered into a definitive agreement to acquire Lichtenau, Germany-based Tesoma. "Kornit is writing the operating system for on-demand sustainable fashionx. Digitizing the production floor is a key pillar of our strategy and the acquisition of Tesoma will allow us to continue accelerating on our mission to transform this industry, with innovative and sustainable, never-before-seen, on-demand textile production solutions," said Ronen Samuel, Kornit Digital Chief Executive Officer. "We've been working with Tesoma's phenomenal engineering team on revolutionary product innovations and unique integration concepts, and I am very excited with our immediate and longer-term roadmap plans." The acquisition is expected to be completed on or before April 1, 2022, following the satisfactory completion of business transition and integration plans.
|
NISN | Hot Stocks08:08 EST Nisun International announces share acquisition agreement with Youjiatian - Nisun International Enterprise Development Group announced that on January 14 Fintech Henan Supply Chain Management, a subsidiary of Fintech Shanghai Digital Technology and controlled affiliate of the Company, entered into a share acquisition agreement with Henan Youjiatian Agricultural Technology and its sole shareholder to acquire a majority equity interest in Youjiatian. Established in 2016, Youjiatian is an agricultural supply chain management company. As a result of the booming development of the agricultural industry in the Henan province, it has recently experienced rapid growth. Pursuant to the Agreement, Henan Fintech agreed to acquire 51% of Youjiatian's equity for a cash consideration of RMB510,000, or approximately $80,280, based on the agreed-upon value of the shares to be acquired. The selling shareholder would be responsible for all debts of Youjiatian incurred prior to the acquisition and pledge the remaining 49% equity as collateral to guarantee the repayment of these debts. Youjiatian agreed to obtain certain land use rights and pledge such rights and all real properties on the land as additional collateral to secure the repayment of the pre-existing debts. As the majority shareholder, Henan Fintech would provide loan funds for Youjiatian's operations, as set forth in the Agreement. The parties further agreed to annual revenue and net income performance targets for Youjiatian as well as a performance-based profit allocation schedule between the two parties. The transaction is expected to close in 90 days.
|
AXP | Hot Stocks08:08 EST American Express raises quarterly dividend from 43c to 52c per share - The company stated that it "plans to increase the regular quarterly dividend on its common shares outstanding by approximately 20%, from 43 cents to 52 cents per share beginning with the first quarter 2022, subject to approval by the company's board of directors."
|
HRZN | Hot Stocks08:07 EST Horizon Technology leads $50M venture loan facility to Autonomy - Horizon Technology announced that on December 14, 2021 it led a $50M venture loan facility to Nextcar Holding Company, Inc. dba Autonomy, a completely digital mobility offering that provides consumers with an affordable way to get access to a vehicle without long-term debt or commitment. Horizon funded $7M of the initial $14M draw.
|
HES | Hot Stocks08:07 EST Hess Corp. announces 2022 E&P capital and exploratory budget of $2.6B - Hess Corp. announced a 2022 exploration and production capital and exploratory budget of $2.6B, of which approximately 80% will be allocated to Guyana and the Bakken. Net production is forecast to average between 330,000 and 340,000 barrels of oil equivalent per day in 2022, excluding Libya. Bakken net production is forecast to average between 165,000 and 170,000 barrels of oil equivalent per day in 2022. The $2.6B budget is allocated as follows: $1.15B for production, $1B for offshore Guyana developments and $450M for exploration and appraisal activities.
|
ASO | Hot Stocks08:06 EST Academy Sports to open at least eight new stores in 2022 - Academy Sports and Outdoors announced that it will open at least eight new stores in 2022 that will fill in certain existing markets in Florida, Georgia, Indiana, Kentucky and Texas, and expand Academy's footprint into Virginia and West Virginia. With these openings, Academy's existing store count will grow to 267 and expand its reach to 18 states. Academy is evaluating additional locations for stores that could also open in 2022. Academy expects the new stores to bring nearly 500 new jobs across the eight communities.
|
TWST | Hot Stocks08:05 EST Twist Bioscience, Artisan Development Labs to engineer cell therapies - Twist Bioscience and Artisan Development Labs announced a collaboration to discover novel antibodies against five undisclosed targets, with an option to expand with additional targets. Under the terms of the collaboration, Twist will leverage its proprietary Library of Libraries to discover novel antibodies directed against Artisan's immunotherapy targets. Artisan will leverage its Immune Cell Engineering Foundry and STAR Guides to develop custom cell therapeutics. Twist will receive upfront technology access and project fees for each program, success-based clinical, regulatory and commercial milestones, as well as royalties on product sales.
|
ICLK | Hot Stocks08:04 EST iClick Interactive Asia names David Zhang as CFO, succeeding Terence Li - iClick Interactive Asia appointed David Tiezhu Zhang as CFO and to the Board of Directors of the company, effective January 31. Zhang is currently Senior Vice President of Finance at iClick, where he leads the company's finance and legal teams. He brings over 25 years of experience in financial management, investment, and business operations to his new positions. Zhang succeeds Terence Li who will step down from his roles as CFO and Director both effective January 31. Li will continue to work closely with iClick as the Chief Strategy Advisor and focus more on the company's new business development.
|
ARIZ FUFU | Hot Stocks08:04 EST Arisz Acquisition to merge with BitFuFu in $1.5B transaction - Finfront Holding Company and Arisz Acquisition announced that they have entered into a definitive business combination agreement that will result in BitFuFu becoming a publicly listed company on NASDAQ under an anticipated ticker symbol "FUFU". The transaction values the Company at a pro forma enterprise value of approximately $1.5 billion. The companies said, "BitFuFu is a fast-growing company in the crypto-mining industry and is dedicated to fostering a secure, compliant, and transparent blockchain infrastructure by providing a variety of stable and intelligent hashrate service solutions. BitFuFu offers a one-stop mining solution for miners of all sizes from institutional customers to individual digital asset enthusiasts. It manages mining machines and mines on behalf of its users, allowing users the option of viewing and managing their rigs conveniently in real-time. BitFufu's innovative technologies are one of the key drivers for ensuring its leadership position in the industry. Its proprietary Aladdin system handles ultra-large scale hashrate management and dispatching. The system has the maximum capacity to simultaneously connect millions of miners and provide services that resolve critical mining problems arising from scalability, efficiency, authenticity, and securing hash power. The Company had a hosting capacity of 140 MW at the end of 2021 across its global mining facilities network and strategic partnership with Bitmain. BitFuFu received early investment from Bitmain, a world-leading cryptocurrency mining hardware manufacturer. The Company has been the only cloud-mining strategic partner of Bitmain to date and has executed a 10-year mining hosting contract with Bitmain, offering it competitive advantages such as preferential access to mining sites, miners, new markets, and improved operational efficiencies." The Transaction values the combined company at an implied fully diluted pro forma enterprise value of approximately $1.5 billion, representing a 4.6x 2022 projected revenue of approximately $330 million, and 3.3x projected December 2022 annualized recurring revenue of approximately $465 million. The Transaction is expected to provide more than $129 million in net cash proceeds to BitFuFu at closing, after transaction expenses and assuming no redemptions of shares by ARIZ's existing public stockholders. Existing BitFuFu stockholders are retaining 100% of their equity in the combined company. The proceeds from the Transaction are expected to fund mining equipment purchases and infrastructure build-out as the Company expands its leadership position in the industry. The BitFuFu and ARIZ Boards of Directors have unanimously approved the proposed merger, which is expected to be completed in the third quarter of 2022, subject to, among other things, regulatory approval, the approval by BitFuFu's and ARIZ's stockholders of the proposed merger and satisfaction or waiver of other customary closing conditions. BitFuFu's management team, led by its founder Leo Lu, will continue to run the Company after the transaction.
|
DFS | Hot Stocks08:03 EST Discover to fill over 1,000 customer care center positions this year - Discover is growing across its credit card and bank lines of business, and to meet its needs, the company is looking to fill more than 1,000 customer care center positions by the end of 2022. This hiring initiative features roles with location flexibility which includes Arizona, Delaware, Illinois, Ohio or Utah. Open positions include customer service representatives, cardmember assistance representatives, underwriters, personal loans specialists, and team leaders.
|
CBIO | Hot Stocks08:02 EST Catalyst Biosciences receives RPDD for CB 4332 for treatment of CFID - Catalyst Biosciences announced the U.S. Food and Drug Administration, FDA, has granted Rare Pediatric Disease Designation, RPDD, for CB 4332 for the treatment of Complement Factor I deficiency, CFID. "The granting of the Rare Pediatric Disease Designation for CB 4332 underscores the significant unmet medical need in pediatric patients with CFID. We are focused on efficiently advancing the development of CB 4332 and our complement medicines portfolio in a number of complement-driven diseases in hematology, nephrology and ophthalmology. We are pleased with the FDA's assessment of CB 4332 as a potential therapy for underserved pediatric patients with CFID and the granting of the RPDD," said Nassim Usman, Ph.D., chief executive officer of Catalyst Biosciences.
|
EBAY | Hot Stocks08:02 EST eBay launches Authenticity Guarantee service for trading cards - eBay announced the launch of its Authenticity Guarantee service for trading cards. Beginning now, single ungraded trading cards (including collectible card games, sports and non-sports) sold for $750+ in the U.S. will be authenticated. By mid-2022, the service will expand to include graded, autograph and patch cards sold for $250+. With the addition of trading cards to eBay's Authenticity Guarantee service, the company now offers authentication in four key enthusiast collector categories, including sneakers, watches, handbags and now trading cards. As one of eBay's top categories, trading cards has been growing at a significant pace -- hitting $2B in transactions in the first half of 2021.
|
CKPT | Hot Stocks08:00 EST Checkpoint Therapeutics trading resumes
|
NCMGY | Hot Stocks07:53 EST Newcrest Mining withdraws from option, farm-in agreement for Cana Brava/Tioloma - Cornerstone Capital Resources announces that Newcrest International has notified Cornerstone and its subsidiary Canabrava Mining S.A. that Newcrest intends to withdraw from the option and farm-in Agreement Cornerstone's Cana Brava and Tioloma properties in Ecuador targeting epithermal gold-silver and porphyry gold-copper deposits in south central Ecuador.
|
BSFC | Hot Stocks07:51 EST Blue Star Foods to receive $5M investment from The Lind Partners - Blue Star Foods announced that it has entered into a securities purchase agreement with Lind Global Fund II LP, an investment entity managed by The Lind Partners, pursuant to which Blue Star will issue and sell a convertible note in the principal amount of $5,750,000, which includes a 15% original issue discount, and a five-year warrant to purchase an aggregate of 1,000,000 shares of common stock exercisable at $4.50. The transaction is subject to the satisfaction of customary closing conditions. Key terms of the secured 24 month note include a 0% interest rate and a fixed conversion price of $5.00 per share, which is a 26% premium to the $3.97 closing price of BSFC on Monday, January 24, 2022. Principal payments are due in 18 monthly installments beginning 180 days after issuance. Under the terms of the note, Blue Star has the right to make principal and interest payments in the form of either cash or common stock.
|
VHIBF | Hot Stocks07:44 EST Vitalhub announces licensing sale of SHREWD WaitLess to Kent, Medway CCG - VitalHub announces a multi-year licensing sale of wholly owned subsidiary Transforming Systems' proprietary SHREWD WaitLess module to the Kent and Medway Clinical Commissioning Group, CCG. The CCG has agreed to a two-year licensing agreement for the SHREWD WaitLess product, which "empowers patients and support system wide load-balancing through the WaitLess App. By presenting combined live waiting times across MIUs, UTCs, WICs and EDs and indicative travel time information across the locality, SHREWD WaitLess provides detailed site and service information for each location, enabling patients to make informed decisions on where they choose to be seen," the company said. "This sale is a testament to the strength of the relationship cultivated with Kent and Medway, and the considerable value driven from the use of our solutions," said Dan Matlow, CEO of VitalHub Corp. "As we begin to emerge from the COVID-19 pandemic and adjust to a 'new-normal', healthcare systems are demonstrating strong demand for digital tools that improve patient overview, and help improve resource utilization and capacity allocation."
|
LMT | Hot Stocks07:43 EST Lockheed Martin sees FY22 cash from operations greater than, equal to $7.9B - Sees FY22 free cash flow greater than, equal to $6B.
|
WSNAF | Hot Stocks07:41 EST Wesana Health appoints Meghna Gaeta as CMO - Wesana Health Holdings announced the appointment of Meghna Gaeta as Chief Marketing Officer. In this role, she will lead Wesana's business marketing strategy. Meghna most recently led a boutique marketing consultancy, working closely with healthcare, retail & start-up tech clients. Wesana also announces it has retained the services of North Equities, an investor communications and public relations company, to assist the Company to enhance its market awareness, and communications strategy. Under the terms of the North Equities engagement, which is for an initial six-month period, North Equities will be paid $70,000 for the six-month term in form of 63,927 restricted stock units of the Company.
|
OSIIF | Hot Stocks07:41 EST Osino Resources announces update on Twin Hills Gold Project - Osino Resources announces an update on infill and step-out drilling at its Twin Hills Gold Project in the Erongo Region of Namibia. The Twin Hills maiden resource was released on April 12th, 2021 including 0.43Moz @ 1.00g/t in the Indicated category and 1.47Moz at 1.08g/t in the Inferred category at a cut-off grade of 0.5g/t. The infill and step-out drill programs are aimed at converting the bulk of the mineralization to the Indicated category and expanding the total resource. Heye Daun, Osino's CEO commented: "These are another set of excellent results from Clouds which are particularly significant as they are outside of the resource envelope and PEA pit design, and thus could have a significant impact on future resource growth... We have planned some immediate follow-up drilling to better define the Clouds shoot at depth and hopefully be able to include some of it in the next resource update, scheduled for April/May 2022."
|
AXTA | Hot Stocks07:40 EST Axalta Coating targets 50% reduction in Scope 1 and 2 GHG emissions by 2030 - Axalta announced its commitment to an absolute reduction of 50% of Scope 1 and 2 greenhouse gas emissions by 2030, on its way to becoming carbon neutral in its operations by 2040 - one decade ahead of the deadline set by the Paris Agreement on Climate Change. In addition, the company has made 10 new sustainability commitments for 2030. Key among these is the commitment to produce sustainability benefits from 80% of Axalta's new product developments.
|
MBRX | Hot Stocks07:39 EST WPD Pharmaceuticals enters amended sublicense agreement with Moleculin Biotech - WPD Pharmaceuticals announced that it has entered into an amended and restated sublicense agreement with Moleculin Biotech. On December 20, 2021, WPD Pharmaceuticals, the Polish subsidiary of the Company, entered into an amendment of its February 2019 sublicense from Moleculin of certain intellectual property rights, including certain rights to Moleculin's Annamycin, WP1066 and WP1122 portfolios to research, develop, manufacture, use, import, offer and sell products derived from these portfolios in the field of human therapeutics in 29 countries, including some countries in Europe. In consideration of the Moleculin sublicense, WPD agreed that it must use commercially reasonable efforts to develop and commercialize Products in the Territories. The amended agreement provides that, in respect of "commercially reasonable development efforts", WPD must spend at least $2,500,000 during the first 4 years of the agreement on the research, development and commercialization of Products and at least $2,100,000 in each of the 5 years thereafter. Accordingly, the total minimum required CRDE is now $13,000,000, amended from $6,500,000. The Company also announced that it has entered into a consent agreement dated December 19, 2021 with Moleculin, WPD Poland, and LPC Enterprises, whereby Moleculin consented to the potential assignment by WPD Poland to LPC of WPD Poland's rights, and the assumption of LPC of the duties and obligations of WPD Poland, under the Sublicense Agreement. The Consent was granted by Moleculin in connection with a convertible promissory note issued by WPD Poland to LPC in the principal amount of US$1,380,000. Moleculin is not a party to the Note. The Note bears interest at a rate of 10% per year, has a maturity date of November 15, 2022, and will be funded as follows: $600,000 on December 5, 2021; $200,000 on January 5, 2022, $200,000 on February 5, 2022, and $200,000 on April 5, 2022. LPC may convert the principal amount and all interest into shares of WPD Poland based on a conversion formula which includes a valuation cap of WPD Poland at 8,000,000. Upon a qualifying event of default under the Note, the Sublicense Agreement would be assigned by WPD Poland to LPC. Moleculin has the right under the Assignment to acquire the Sublicense Agreement in the event of default.
|
GLUE | Hot Stocks07:37 EST Monte Rosa Therapeutics, Yeda announce license, research collaboration - Monte Rosa Therapeutics announced a license and research collaboration agreement with Dr. Nir London and the Yeda Research and Development Company, the commercial arm of the Weizmann Institute of Science, which aims to accelerate the discovery and development of novel covalent molecular glue degraders leveraging CoLDR technology. Dr. London and his team at the Weizmann Institute developed CoLDR technology, which uses covalent chemical inhibitors as a targeting system for selective cargo release or for site-specific labeling. This technology has the potential to be applied to the targeted protein degradation field, including the development of novel molecular glue degraders for cancer and other diseases. "We are thrilled to partner with Dr. London and his team at the Weizmann Institute to utilize CoLDR technology to advance the field of targeted protein degradation through the identification of novel E3 ligases and covalent E3 ligase recruiters suitable for molecular glue degradation," said Sharon Townson, Ph.D., Chief Technology Officer of Monte Rosa. "Through this research collaboration, we hope to not only expand the E3 ligase-target universe-we hope to further unlock therapeutically relevant proteins that were previously considered inadequately drugged by other small molecule approaches."
|
MNMD | Hot Stocks07:37 EST MindMed announces FDA approval of IND for MM-120 - Mind Medicine announced that the U.S. FDA has cleared MindMed's Investigational New Drug application, allowing the company's Phase 2b dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder to proceed. The previously announced clinical hold on the IND was lifted following MindMed's rapid responses for additional information related to the participant monitoring protocol in the upcoming study. The company is working with study investigators and clinical trial sites to prepare for participant enrollment, which is expected to start in early 2022.
|
TBK | Hot Stocks07:37 EST Triumph Bancorp announces extension of exchange offer - Triumph Bancorp announced that it extended its offer to holders of $70.0 million in aggregate principal amount of its 3.50% fixed to floating rate subordinated notes due 2031, issued August 26, 2021, to exchange the Old Notes for a like principal amount of notes with identical terms other than that such new notes have been registered under the Securities Act of 1933, as amended. The exchange offer, which had been scheduled to expire on January 24, 2022 at 5:00 p.m., New York City time, will now expire at 5:00 p.m., New York City time, on February 1, 2022, unless further extended by Triumph Bancorp. All other terms, provisions and conditions of the exchange offer will remain in full force and effect. Computershare Trust Company, N.A. is serving as exchange agent for the exchange offer. Triumph Bancorp said it has been informed by the exchange agent that, as of January 24, 2022 at 5:00 p.m., New York City time, $67,500,000 in aggregate principal amount of the Old Notes had been tendered in the exchange offer. This amount represents approximately 96.4% of the Old Notes.
|
AJRD LMT | Hot Stocks07:36 EST Aerojet Rocketdyne sees FTC voting to sue to block Lockheed Martin transaction - The company said, "Earlier this month, Lockheed Martin (LMT) and Aerojet Rocketdyne (AJRD) agreed with the Federal Trade Commission that we would not close the transaction before Jan. 27, 2022, to enable the parties to discuss the scope and nature of the merchant supply and firewall commitments previously offered by Lockheed Martin. Aerojet Rocketdyne has been advised by the FTC that its concerns regarding the transaction cannot be addressed adequately by the terms of the proposed consent order. We believe it is highly likely that the FTC will vote to sue to block the transaction and expect they will make a decision before Jan. 27, 2022. If the FTC sues to block the transaction, Lockheed Martin could elect to defend the lawsuit or terminate the merger agreement. Aerojet Rocketdyne continues to believe in the benefits of the transaction for the United States and its allies, the industry, and all of the company's stakeholders."
|
CKPT | Hot Stocks07:35 EST Checkpoint Therapeutics announces results from trial of cosibelimab - Checkpoint Therapeutics announced "positive" topline results from its registration-enabling clinical trial evaluating the safety and efficacy of its anti-PD-L1 antibody, cosibelimab, administered as a fixed dose of 800 mg every two weeks in patients with metastatic cutaneous squamous cell carcinoma, cSCC. The study met its primary endpoint, with cosibelimab demonstrating a confirmed objective response rate, ORR, of 47.4% based on independent central review of 78 patients enrolled in the metastatic cSCC cohort using Response Evaluation Criteria in Solid Tumors version 1.1 criteria. The median duration of response had not yet been reached at the data cut-off point. Safety data across 201 patients with advanced cancers enrolled and treated in all cohorts of the ongoing study remain consistent with those previously reported, with the majority of treatment-emergent adverse events reported as Grade 1 or 2 in severity. Based on these results, Checkpoint intends to submit a Biologics License Application, BLA, to the U.S. Food and Drug Administration for cosibelimab later this year, to be followed by a marketing authorization application, MAA, submission in Europe and additional potential submissions in markets worldwide. James Oliviero, President and Chief Executive Officer of Checkpoint, stated, "We are thrilled to report these topline results from our pivotal trial of cosibelimab in metastatic cutaneous squamous cell carcinoma. We believe the strong ORR result is attributable to cosibelimab's differentiated, two-fold mechanism of action of engaging both T-cells and natural killer cells, while also demonstrating a potential favorable safety profile through its binding to PD-L1, reported in literature as associated with lower rates of severe or worse adverse events as compared to PD-1 therapy."
|
NEP | Hot Stocks07:35 EST NextEra Energy Partners continues with leadership succession process - As part of a planned leadership succession process, the board of directors of NextEra Energy Partners, appointed John Ketchum CEO effective March 1. Jim Robo will remain chairman of NextEra Energy Partners' board until the annual meeting of unitholders, scheduled for April 20, 2022. At that time, it is anticipated that Ketchum will succeed Robo as NextEra Energy Partners' board chair and as one of the four NextEra Energy Partners' directors nominated for election by unit holders. Along with these changes, the company is announcing other senior leadership moves, effective March 1 including Rebecca Kujawa is appointed president, NextEra Energy Partners, succeeding Ketchum. Kujawa is presently NextEra Energy Partners' CFO. Kirk Crews is appointed CFO, NextEra Energy Partners, succeeding Kujawa. It is anticipated that Crews will be appointed a board director on the date of the annual meeting. These changes coincide with the leadership succession process that was announced by NextEra Energy. Ketchum has a diverse business, finance and legal background with a broad range of experiences across key leadership roles at NextEra Energy and NextEra Energy Resources. Since being appointed a NextEra Energy Partners' board director in 2016, he served for three years as NextEra Energy Partners' CFO and three years as its president.
|
SIGA | Hot Stocks07:33 EST Siga Technologies announces preclinical research collab with Bioarchitech - SIGA Technologies announced that it entered into a collaboration with Bioarchitech, a United Kingdom-based biotech company developing immunotherapy for the treatment of cancer. The research collaboration will investigate TPOXX in combination with Bioarchitech's proprietary vaccinia-based immunotherapy platform in preclinical studies. This platform utilizes engineered antibodies and other proteins expressed within the genome of an oncolytic virus. Cancer cells infected by the vaccinia virus release these potent immunotherapy molecules into the tumor where they orchestrate the destruction of malignant cells using the patient's own immune system. "TPOXX has potential as a powerful tool to better enable success of vaccinia-based immunotherapies," said Dr. Phil Gomez, CEO of SIGA. "TPOXX, a potent antiviral drug to vaccinia, could potentially increase the immunotherapeutic effect of such therapies by allowing the safe use of higher doses of vaccinia vectors. We are pleased to enter into this collaboration with Bioarchitech, an innovator of next generation cancer immunotherapies."
|
ICNAF | Hot Stocks07:33 EST Icanic Brands to acquire LEEF Holdings - Icanic Brands Company is pleased to announce that the Company has entered into a definitive agreement with LEEF Holdings. The company said, "LEEF is one of the largest cannabis extraction companies in the state of California and is a leading provider of bulk concentrates to many of the largest brands in the state. It is led by an expert group of legacy operators with decades of experience in organic soil-based farming and sophisticated extraction practices. LEEF's manufacturing capabilities include a 12,000 sq.ft state of the art extraction and manufacturing facility with up to 45 tons of biomass throughput per month and up to 3,000 liters of distillate extraction capability per month. Headquartered in Willits, California, LEEF's core manufacturing competencies include ethanol extraction, hydrocarbon extraction. and solventless extraction. LEEF also has an edibles production line and is in the process of building out a 45,000 sq.ft mid-stream processing facility which will allow it to dry its own product and provide additional services including processing, distribution and delivery to its customers. LEEF also recently received a 186.7 acre cultivation land use permit, which will make it the owner of one of the largest cannabis cultivation sites in California. The site sits on over 1,900 acres of prime California real estate. Since inception, LEEF has experienced significant year over year growth with strong and consistent gross margins and positive cash flow. From 2019 to the end of 2021, LEEF experienced revenue growth exceeding 100%. With the build out of the cultivation site, LEEF will be able to provide consistency, quality and quantity to its customers and its' margins are expected to increase substantially as it gains vertical efficiencies with its in-house supply chain. In addition to its extraction and distribution capabilities, LEEF owns and operates the LEEF Organics, Heady, and Paleo Paw brands and currently operates and has an option to purchase the highly sought after Real Deal Resin brand. These brands will add to Icanic's current brand portfolio which currently includes its award winning GanjaGold and Taylor's brands. It is expected that LEEF's expertise in manufacturing and supply chain management will allow for significant operating synergies on a go forward basis including reduced input costs and enhanced manufacturing efficiencies." Under the terms of the Agreement, the Company will acquire all the issued and outstanding shares of common stock of LEEF whereby LEEF will complete a statutory triangular merger under the Nevada Revised Statutes with a wholly-owned subsidiary of the Company. The purchase price will be comprised of the Closing Purchase Price and earn-out payments, tied to achieving certain revenue targets following the completion of the Acquisition. The initial payment forming part of the Purchase Price will be equal to the higher of US$120,000,000 or two times the trailing 12-months revenue of LEEF for the period ended September 30, 2021. The Closing Purchase Price will be satisfied in full through the issuance of common shares of the Company, at an issue price per share equal to the 30-day volume-weighted average trading price of the Icanic Shares on the Canadian Securities Exchange for the period ending on the business day prior to closing. The Acquisition is anticipated to be completed during Q1 2022 and is subject to customary closing conditions, regulatory approvals and the approval of LEEF shareholders.
|
NEE | Hot Stocks07:32 EST NextEra Energy names John Ketchum president and CEO - As part of a planned leadership succession process, the board of directors of NextEra Energy announced a series of senior leadership appointments, effective March 1, 2022, aimed at paving the way for the next generation of company leadership. John Ketchum, a 19-year veteran of NextEra Energy, is named president and chief executive officer. He will report directly to the NextEra Energy, Inc. Board of Directors. Jim Robo, the current chairman and CEO, will become executive chairman for a transition period, and it is anticipated that Mr. Ketchum will also be appointed to the company's board of directors effective March 1. Along with these changes, the company is announcing other senior leadership moves, including: Eric Silagy, president and CEO of Florida Power & Light Company, will take on the added responsibility of chairman, FPL. Rebecca Kujawa is named president and CEO, NextEra Energy Resources, LLC, succeeding Mr. Ketchum. Ms. Kujawa is presently NextEra Energy's executive vice president, finance and chief financial officer. Kirk Crews is named executive vice president, finance and CFO, NextEra Energy, Inc., succeeding Ms. Kujawa. Mr. Crews is presently vice president, business management, NEER.
|
LMT AJRD | Hot Stocks07:32 EST Lockheed Martin says 'highly likely' FTC will vote to sue to block Aerojet deal - Earlier this month, Lockheed Martin (LMT) and Aerojet Rocketdyne (AJRD) agreed with the Federal Trade Commission that the parties would not close the transaction before Jan. 27, 2022, to enable the parties to discuss the scope and nature of the merchant supply and firewall commitments previously offered by Lockheed Martin. Lockheed Martin has been advised by the FTC that its concerns regarding the transaction cannot be addressed adequately by the terms of a consent order. Lockheed Martin believes it is highly likely that the FTC will vote to sue to block the transaction and expects they will make a decision before Jan. 27, 2022. If the FTC sues to block the transaction, Lockheed Martin could elect to defend the lawsuit or terminate the merger agreement.
|
WEI | Hot Stocks07:30 EST Weidai changes ratio of its ADSs - Weidai announced that it will change the ratio of its American depositary shares, or ADSs, representing its Class A ordinary shares from one ADS representing one Class A ordinary share to one ADS representing five Class A ordinary shares. The effect of the ratio change on the ADS trading price on the NYSE will take place at the open of trading on January 26. This change supersedes the original plan of three-to-one ADS ratio change as disclosed in the press release issued by the Company on January 13. For Weidai's ADS holders, the change in the ADS ratio will have the same effect as a one-for-five reverse ADS split. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than five times the ADS price before the change.
|
SRRA | Hot Stocks07:30 EST Sierra Oncology trading resumes
|
AOTVF | Hot Stocks07:28 EST Ascot Resources provides update on Premier Gold Project - Ascot Resources is pleased to provide an update on the Premier Gold Project located in the Golden Triangle of northwestern British Columbia with respect to progress to date and development plans in 2022. This release includes a detailed project schedule and an updated capital cost estimate for the project. Building on the success of the Early Works program in 2021, Ascot remains on track to commence full-scale construction activities and underground development in April 2022, with first gold pour targeted for the first quarter of 2023. The Company is also pleased to announce the receipt of the Environmental Management Act Permit, completing the JPAA for the project. Derek White, President and CEO of Ascot commented, "The Company made considerable progress on pre-construction and Early Works activities in 2021 and is now pleased to have received the final operating permit for the Premier Gold Project. Despite facing various challenges last year, including the loss of key equipment at sea due to weather events, the Ascot team stepped up in meaningful ways and adapted to stay the course towards production, positioning us to execute on the project in 2022. We are excited to get the Premier mill restarted with first gold pour anticipated around this time next year. The Golden Triangle of northwestern B.C. has been a focal point for Canadian mining mergers and acquisitions in recent years, and Ascot has one of only three mills in the entire region. Notwithstanding project delays and cost pressures, we are confident in our ability to execute on the remainder of project construction during 2022, on the path to becoming Canada's next gold producer."
|
OCUP | Hot Stocks07:25 EST Ocuphire Pharma to host virtual R&D Day on January 31 - Ocuphire Pharma announced that it will host a virtual investor R&D Day on Monday, January 31, 2022 from 10:00am to 12:15pm ET. The Ocuphire Investor R&D Day will feature six ophthalmic Key Opinion Leaders from refractive surgery, optometry and retina practice areas who will share their thoughts on three large unmet indications addressed by Ocuphire's two late-stage clinical drug assets. Two leading indications for Nyxol, reversal of pharmacologically-induced mydriasis and presbyopia will be discussed as will APX3330 for diabetic retinopathy. Topics will include a review of previous Phase 2 and 3 readouts from 2021, status updates for ongoing clinical trials, a preview of expected 2022 catalysts including a potential NDA submission for the RM indication, and prospective commercial dynamics and competitive positioning of Nyxol in RM and presbyopia, and APX3330 in retinal diseases. Ocuphire's lead product candidate, Nyxol eye drops, is a non-selective alpha-1 and alpha-2 adrenergic inhibitor for the treatment of refractive conditions; its second product candidate, APX3330, is an first-in-class oral Ref-1 inhibitor with a novel, dual anti-VEGF and anti-inflammatory mechanism for the treatment of diabetic retinal diseases. The agenda for the Investor R&D day will kick-off with Mina Sooch, CEO of Ocuphire providing a company overview. Mark Kelley, Ph.D., scientific advisor for the APX Program and discoverer of the Ref-1 target, will provide an overview of APX3330's mechanism and preclinical data. Drs. Kaiser and Boyer will present APX3330's prior clinical safety data and provide an update on the ongoing ZETA-1 Phase 2b DR study. Drs. Karpecki and Jackson will discuss the positive Phase 3 MIRA-2 results for Nyxol in reversal of mydriasis, and the significant addressable market where there are currently no commercially available treatment options. Bindu Manne, Ocuphire's newly appointed Head of Market Development and Commercialization, will join the KOLs and discuss the current patient-physician dynamic and the utility of Nyxol for RM across different eyecare practice areas. Lastly, Drs. Pepose and Katz will discuss the positive VEGA-1 Phase 2 results in light of the recent launch of Vuity by Allergan, the first FDA-approved eyedrop treatment for presbyopia, and provide updates on the planned VEGA Phase 3 clinical programs.
|
CKPT | Hot Stocks07:25 EST Checkpoint Therapeutics trading halted, news pending
|
SRRA | Hot Stocks07:24 EST Sierra Oncology trading halted, news pending
|
SRRA | Hot Stocks07:24 EST Sierra provides update to support future commercialization of momelotinib - Sierra Oncology announced it has entered into a term loan agreement with Oxford Finance, That is designed to primarily support the commercial preparation and potential launch of momelotinib, an investigational agent for the treatment of myelofibrosis, a rare form of blood cancer. The Company estimates it had cash and cash equivalents of $104.7m as of December 31 . Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra Oncology, said, "Our strong cash position together with the term loan facility with Oxford create great financial optionality for us as we move towards an NDA filing and potential approval of momelotinib." Under the terms of the loan agreement with Oxford Finance, LLC, Sierra drew an initial $5 million term loan at closing. The company has the ability to access up to an additional $120 million in a series of tranches, $70 million of which are based on certain pre-determined milestones, including US regulatory approval and financing, and $50 million is at the lender's discretion. In addition, the Company's Series B Warrants expire 75 days from today, and if fully exercised, would provide a total of $33.3 million in proceeds
|
SRRA | Hot Stocks07:24 EST Sierra provides update to support future commercialization of momelotinib - Sierra Oncology announced it has entered into a term loan agreement with Oxford Finance, That is designed to primarily support the commercial preparation and potential launch of momelotinib, an investigational agent for the treatment of myelofibrosis, a rare form of blood cancer. The Company estimates it had cash and cash equivalents of $104.7m as of December 31 . Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra Oncology, said, "Our strong cash position together with the term loan facility with Oxford create great financial optionality for us as we move towards an NDA filing and potential approval of momelotinib." Under the terms of the loan agreement with Oxford Finance, LLC, Sierra drew an initial $5 million term loan at closing. The company has the ability to access up to an additional $120 million in a series of tranches, $70 million of which are based on certain pre-determined milestones, including US regulatory approval and financing, and $50 million is at the lender's discretion. In addition, the Company's Series B Warrants expire 75 days from today, and if fully exercised, would provide a total of $33.3 million in proceeds
|
LTRX | Hot Stocks07:21 EST Lantronix to exhibit solutions at BICSI Winter 2022 conference - Lantronix announced it will exhibit at the BICSI Winter 2022 Conference & Exhibition. Taking place Jan. 30-Feb. 3, 2022, the event is being held at the Orlando World Center Marriott Resort & Convention Center. Lantronix will exhibit at booth 1033."At BICSI, Lantronix will showcase innovative solutions for Smart Cities and intelligent buildings, including PoE lighting and ITS solutions as well as products for Federal and local government and data centers," said Jacques Issa, VP of Marketing at Lantronix. "Our end-to-end IoT solutions uniquely position us in this fast-growing market. According to Guidehouse Insights, the market for PoE in digital buildings is expected to grow at a CAGR of 20 percent with the total market expected to increase to over $615 million by 2030."
|
TNMCF | Hot Stocks07:19 EST Titan Mining sees 2022 production 64M-68M pounds of payable zinc - Production guidance for 2022 is estimated between 64-68 million pounds of payable zinc representing a 35-43% increase from 2021. C1 Cash Cost for 2022 is estimated between $0.94 and $0.98 per payable pound and AISC is estimated between $0.98 and $1.03 per payable pound. Both C1 Cash Cost and AISC are highly dependent on treatment charges which won't be known with certainty until the end of H1 2022. Titan estimates that for every $10 per tonne change to the treatment charge, C1 Cash Cost and AISC are impacted by approximately $0.01 per pound of payable zinc. C1 Cash Cost and AISC guidance for 2022 reflect an estimated annual treatment charge of $175 per tonne. Zinc production at ESM is expected to increase moderately in the second half of the year as mining activity is expected to ramp up at the #2 mine open pits. The financial success at ESM's operations will allow for more discretionary expenditure to be focused on exploration activities in 2022.
|
TNMCF | Hot Stocks07:18 EST Titan Mining reports zinc production of 47.5M payable pounds in 2021 - Titan Mining Corporation is pleased to release preliminary fourth quarter and full year 2021 production results and provide 2022 operating, capital and exploration expenditure guidance. 2021 Highlights: Improved safety performance, decreasing incident severity rate 95%. Produced 47.5 million payable pounds of zinc in 2021, a record since re-opening of the Empire State Mine. Implemented a fixed price arrangement hedging program covering 50% of H2/21 payable production and 60%, or 8.4 million pounds, of forecasted Q1/22 payable production. Declared an inaugural special cash dividend of C$0.01 per share at the end of Q3 and declared a second special dividend of C$0.01 per share at the end of Q4. Extended credit facility maturity dates with each of the Bank of Nova Scotia and a company controlled by Titan's Executive Chairman to April 3, 2023 and April 5, 2023 respectively. $2,000,000 payment made against the BNS facility in Q4 2021. Total payable zinc production from ESM was 12.2 million pounds in Q4 2021 for total annual payable production of 47.5 million pounds. 2021 production is preliminary and subject to change when the Company releases its Q4 2021 and audited full-year 2021 financial and operating results in March 2022.
|
CHK | Hot Stocks07:17 EST Chesapeake raises 5-year free cash flow outlook to more than $9B - Increases cumulative five-year free cash flow outlook to more than $9B at today's commodity strip prices; portfolio to generate approximately 75% of 2022 projected cash flow from natural gas assets and 25% from oil assets, post closing of transactions.
|
TLRY | Hot Stocks07:17 EST Tilray expands medical cannabis product offering in Australia - Tilray Brands announced the expansion of its medical cannabis product offering in Australia and a new medical cannabis e-learning platform for healthcare providers. Denise Faltischek, Head of International and Chief Strategy Officer, said, "Tilray is transforming the industry globally with our highly scalable footprint and portfolio of diverse cannabis products. As medical cannabis demand increases worldwide, we remain committed to providing healthcare professionals and patients with safe and reliable access to the highest-quality medical cannabis products." Faltischek continued, "After listening to patient feedback and leveraging learnings from our operations in Germany, we are excited to be introducing new products in Australia that meet consumer needs." Tilray's product offering in Australia approved under the Therapeutic Goods Administration, TGA, Special Access and Authorized Prescriber Scheme is centered around its whole flower options ranging from balanced 1:1 whole flower, including mid-range, and high THC varieties of 15g bag GMP-Certified medical cannabis whole flower.
|
VIEW SKSBF | Hot Stocks07:16 EST View Inc. Smart Windows to be featured in Skanska office project in Seattle - View, Inc. (VIEW) has been selected by global construction and development company Skanska (SKSBF) to be featured in The Eight, a Class-A high-rise office tower and one of the first buildings in the Bellevue Central Business District to feature smart windows.
|
CHK | Hot Stocks07:16 EST Chesapeake expects to increase annual base dividend 14% starting in Q2 - Expected to increase annual base dividend by approximately 14% from $1.75 to $2.00 per share beginning in the second quarter of 2022, reflecting the cash flow accretion of transaction.
|
CATC | Hot Stocks07:15 EST Cambridge Bancorp raises dividend 5% to 64c - On January 24 the Company's Board of Directors declared a quarterly cash dividend of 64c per share, which is payable on February 24 to shareholders of record as of the close of business on February 10. This represents an increase of 3c, or 5%, as compared to the 61c dividend paid in the Q4. The Company did not repurchase any shares under its previously announced share repurchase program during the three months and year ended December 31, 2021.
|
MSSTF OTSKY | Hot Stocks07:15 EST Mindset Pharma enters manufacturing agreement with CDMO - Mindset Pharma (MSSTF) announced that it has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization, CDMO, for the production of pharmaceutical grade batches of Mindset's next-generation psilocybin drug candidate, MSP-1014. "Following our co-development announcement with the McQuade Center for Strategic Research and Development, a member of the Otsuka Pharmaceuticals (OTSKY) family of companies, for our short-duration compounds, we continue to receive interest from potential partners for our wider portfolio of differentiated next-generation drug candidates. As such, our manufacturing agreement with a leading CDMO positions MSP-1014 well for partnership opportunities to advance this optimized compound to human clinical trials," said James Lanthier, Chief Executive Officer of Mindset. "In preclinical trials, MSP-1014 has shown improved efficacy and safety compared to first-generation psilocybin. Also, it has demonstrated pharmacological diversity making it potentially suitable for both in clinic treatment approaches and as a take-home medicine."
|
VZ | Hot Stocks07:13 EST Verizon sees 2022 capital spending $16.5B-$17.5B - Capital spending, excluding C-Band, in the range of $16.5 billion to $17.5 billion, a decrease from $18.2 billion in 2021, as the company has started its progress towards lower capital intensity. Additional expenditures related to the deployment of the company's C-Band 5G network are expected to be in the range of $5 billion to $6 billion as the company continues to build out the initial markets and begins preparations for deploying Phase 2 spectrum.
|
GOOG... | Hot Stocks07:12 EST Sibros closes $70M Series B funding to power connected vehicle system - Sibros announced its $70M Series B funding round led by Energy Impact Partners, EIP, with participation from Fontinalis Partners, Google (GOOG;GOOGL), Iron Pillar, Qualcomm Ventures (QCOM) and existing investors Nexus Venture Partners and Moneta Ventures. "The funding will be used to fuel the company's expansion to meet strong global demand and deliver large customer deployments of its vertically integrated connected vehicle platform," the company said. By connecting software and data seamlessly from edge-to-cloud in one vertically integrated system, Sibros helps automakers "accelerate time-to-market, reduce code defects and enable hundreds of connected vehicle use cases at global scale," the company added. "Today is an incredible milestone for Sibros as we welcome some of the most influential names invested in the future of clean energy, cloud and autotech who join our mission of powering the connected vehicle ecosystem with a vertically integrated solution," stated Hemant Sikaria, CEO and co-founder of Sibros. "The past two years have been a period of extreme growth at Sibros as we track towards being deployed on many millions of vehicles and we're thrilled to have the support of investors who believe in our team and understand the problem we are solving."
|
VZ | Hot Stocks07:12 EST Verizon reports Q4 Business retail postpaid net additions 391K - Business reported 391,000 wireless retail postpaid net additions in fourth-quarter 2021, including 222,000 phone net additions. This was the best quarterly phone net addition performance for Business since the onset of the pandemic.
|
VLNS | Hot Stocks07:11 EST Valens launches Versus - The Valens Company announced the launch of Versus, an evolution of its Verse value brand. The launch involves the introduction of two net new Versus product lines this week, plus a rebranding of the full Verse portfolio this spring, for a total of approximately 20 SKUs across product categories.Valens is also launching its new ultra-premium brand, Contraband, this week with two sizes of CNDYLND flower.
|
VZ | Hot Stocks07:11 EST Verizon reports Q4 Consumer wireless retail postpaid net additions of 667K - In fourth-quarter 2021, Consumer reported 667,000 wireless retail postpaid net additions. This consisted of 336,000 phone net additions and 369,000 other connected device net additions, offset by 38,000 tablet net losses. Consumer also reported 85,000 wireless prepaid net losses, which included TracFone results since November 23. Consumer reported 51,000 Fios Internet net additions in fourth-quarter 2021, and 339,000 Fios Internet net additions in full-year 2021. Consumer Fios revenues were $2.9 billion in fourth-quarter 2021, an increase of 5.6 percent year over year. Consumer reported 69,000 Fios Video net losses in fourth-quarter 2021.
|
VBNK | Hot Stocks07:11 EST VersaBank announces change in TSX ticker symbol to 'VBNK' - VersaBank announced that effective at market open on Tuesday, January 25,, the Bank's common shares will begin trading on the Toronto Stock Exchange under the ticker symbol "VBNK", which replaces the Bank's previous ticker symbol "VB". The change was made to align the Bank's ticker symbol on the TSX with its ticker symbol on Nasdaq.
|
VZ | Hot Stocks07:10 EST Verizon reports Q4 Broadband net additions 106,000 - 106,000 total broadband net additions, defined as wireline and fixed wireless, an increase of 30,000 total broadband net additions year over year. 78,000 fixed wireless net additions, an increase from 55,000 fixed wireless net additions in third-quarter 2021. 55,000 Fios Internet net additions in fourth-quarter 2021. In full-year 2021, Verizon reported 360,000 Fios Internet net additions, the best annual performance since 2014. Total Fios revenues were $3.2 billion in fourth-quarter 2021, an increase of 5.7 percent year over year. Full-year 2021 Fios revenues were approximately $12.7 billion, up 4.6 percent year over year.
|
ATHA | Hot Stocks07:09 EST Athira Pharma announces initiation of patient dosing in SHAPE trial of ATH-1017 - Athira Pharma announced that patient dosing has begun in SHAPE, a Phase 2 clinical trial of ATH-1017 for the treatment of Parkinson's disease dementia and Dementia with Lewy bodies. ATH-1017 is a small molecule designed to enhance the activity of Hepatocyte Growth Factor, HGF, and its receptor, MET, to impact neurodegeneration and regenerate brain tissue. "The initiation of SHAPE is an important milestone in the advancement of our clinical development of ATH-1017. This small molecule is designed to impact neurodegeneration by focusing on network recovery and information transmission in the brain," said Hans Moebius, M.D., Ph.D., Chief Medical Officer at Athira. "SHAPE incorporates key endpoints to measure cognition, function and behavior, as well as including exploratory endpoints for motor function. We are excited to expand our clinical development of ATH-1017 with the SHAPE trial in other dementia indications that affect so many around the world, beyond Alzheimer's disease."
|
EQX | Hot Stocks07:09 EST Equinox Gold sees FY22 production 625,000-710,000 ounces of gold - Equinox Gold announces 2022 production guidance of 625,000 to 710,000 ounces of gold, increasing from 2021 production of 602,100 ounces of gold. Cost guidance includes cash costs of $1,080 to $1,140 per ounce and all-in-sustaining costs, or AISC, of $1,330 to $1,415 per ounce of gold sold. Guidance does not include production from the Mercedes Mine as the previously announced sale is expected to close around the end of the first quarter of 2022. Christian Milau, CEO of Equinox Gold, commented: "Our 2022 guidance represents the fourth consecutive year of production growth at Equinox Gold and includes production that will come from our new Santa Luz mine in Brazil, which has commenced commissioning. Production is forecast to increase quarter over quarter, with 60% of gold production and more than 85% of operating cash flow anticipated in the second half of the year. We continue to advance toward becoming a million-ounce producer by investing in our producing assets and bringing new mines to production. Our 2022 cost estimates reflect $195M of sustaining capital investment in our mines as well as inflationary pressures occurring industry-wide, including significant increases to fuel and other consumables. Our key focus for 2022 is construction at our Greenstone project in Ontario, with a budget of $326M for construction capital."
|
NVRO MDT | Hot Stocks07:09 EST Nevro responds to Medtronic's announcement of FDA approval of PDN - Nevro (NVRO) responded to Medtronic's (MDT) announcement of FDA approval for painful diabetic neuropathy (PDN). "PDN represents a very large potential market, and having another competitor validate this large opportunity speaks to its attractiveness," stated D. Keith Grossman, Chairman, CEO and President of Nevro. "We are very proud of our SENZA-PDN study, the largest, prospective SCS trial conducted for this patient population, generating Level 1 clinical data that we believe has moved the field and the therapy forward. The trials presented by our competitor to support its FDA submission makes especially clear that our proprietary, paresthesia-free 10 kHz Therapy is uniquely suited to treat PDN patients. In fact, a recent review of spinal cord stimulation evidence for painful diabetic neuropathy concluded, 'High-frequency 10 kHz SCS offers several advantages over low frequency SCS, including greater pain relief, a higher proportion of patients achieving treatment success, paresthesia-independence, and evidence of improved neurological function. Neuromodulation with SCS, especially with 10 kHz SCS, offers a pathway forward for improving the lives of PDN patients.'" Dr. David Caraway, Nevro's Chief Medical Officer added, "Instead of the large clinical trial it has been promising to the Pain and Diabetes clinical communities for these patients, Medtronic has simply reintroduced two small European studies from 2014. One of these studies was actually sponsored by another competitor and did not even use Medtronic's products. Both of these low-frequency, SCS trials required paresthesia delivery and demonstrated results that were dramatically inferior to the outcomes generated in our landmark SENZA-PDN trial, a fact widely recognized by our clinicians since the publication of the SENZA-PDN trial results. Unfortunately, these much smaller trials provide no new evidence to further advance the field, drive adoption or expand payer coverage. We believe the significant, durable outcomes from our SENZA-PDN randomized, controlled trial speak for themselves, and we are disappointed in the disparity of standards supporting these two FDA approvals."
|
SLI | Hot Stocks07:08 EST Standard Lithium signs LOI with Koch for lithium take-off, material procurement - Standard Lithium has signed a Letter of Intent, LOI, with Koch Minerals & Trading for the purchase of lithium chemical off-take and the procurement of key raw materials. The principal aim of the LOI is to develop a market-based pricing mechanism for KM&T to procure lithium hydroxide produced by Standard Lithium at the South West Arkansas Project. KM&T is also expected to assist the Company with the effective procurement of key raw materials and chemical reagents by leveraging Koch's expertise, networks and global scale. "Koch is a significant investor in Standard Lithium, and we are excited to expand on this strategic relationship. Developing a market-based pricing off-take structure with KM&T at our South-West Arkansas project will allow the Company to benefit from the projected high prices for lithium chemicals in the coming decade and beyond," said Robert Mintak, Standard Lithium's CEO. "Additionally, the ability to leverage KM&T's substantial purchasing and commodity trading capabilities to optimize the price, quality and quantity of reagents required to operate the plants in the future, which is meaningful both for financing these projects as well as their successful operation."
|
VZ | Hot Stocks07:08 EST Verizon reports Q4 Wireless retail postpaid net additions 1.058M - Total wireless service revenue of $17.8 billion, a 6.5 percent increase year over year, driven by a combination of higher ARPA, volume growth and the contribution from the acquisition of TracFone Wireless, which was completed on November 23. Total retail postpaid churn of 1.01 percent, and retail postpaid phone churn of 0.81 percent. 1,058,000 retail postpaid net additions, including 558,000 phone net additions, resulting in 142.8 million total retail connections.
|
MCLD | Hot Stocks07:08 EST mCloud Technologies signs MOU with Aramco - mCloud Technologies announced it had signed a Memorandum of Understanding, or MOU, with Aramco. The MOU sees mCloud joining forces with Aramco to explore the co-development of a digital technology hub for delivering ESG solutions in the Kingdom of Saudi Arabia. This hub would enable both parties to jointly develop new AI-powered innovations to facilitate the carbon reduction of complex energy-intensive assets throughout the Kingdom and abroad. Additionally, mCloud plans to develop a center of excellence that will serve as a home base for a dedicated team of ESG and digital transformation experts based in Saudi Arabia.
|
VZ | Hot Stocks07:07 EST Verizon CFO says delivered 'strong earnings performance' in Q4 - "Verizon delivered another strong earnings performance this quarter," said Verizon Chief Financial Officer Matt Ellis. "Our financial discipline enabled us to deliver attractive service revenue growth and profitability this quarter as we expanded our portfolio with the TracFone acquisition and saw strong demand for our products and services. In 2021 we delivered on raised adjusted EPS expectations, grew revenue, achieved our $10 billion cost savings goal, and funded our C-Band spectrum investment."
|
OSUR | Hot Stocks07:07 EST OraSure expands HIV oral swab in-home test into Europe - OraSure Technologies announced that it has launched its OraQuick HIV Self-Test, an oral swab in-home test for HIV-1 and HIV-2, into Europe. The test will be available in six European countries: United Kingdom, Germany, France, Italy, Spain and Portugal. "We are currently seeing an increase in HIV testing policies, as well as the rise of HIV prevalence around the globe," said Giffin Daughtridge, MD, MBA, Senior Director of Infectious Disease Diagnostics for OraSure Technologies, Inc. "Having initially launched in the U.S. in 2012, we focused on regions in need during the last decade, distributing 76 million tests worldwide, many of which were in Sub-Saharan Africa. We're now expanding into European countries to give people there more choice and access to HIV self testing."
|
CHK COP | Hot Stocks07:06 EST Chesapeake names Josh Viets as COO - Chesapeake Energy (CHK) announced that Josh Viets has been appointed Executive Vice President and COO, effective February 1. For the last 20 years, Viets has worked in operational positions of increasing importance at ConocoPhillips (COP). He most recently served as Vice President, Delaware Basin and previously held leadership positions in operations, engineering, subsurface, and capital project across the ConocoPhillips portfolio.
|
SSTK | Hot Stocks07:06 EST Shutterstock raises dividend 14% to 24c - Shutterstock announced that its Board of Directors has declared a cash dividend of 24c per share of outstanding common stock on January 24, payable on March 17, to stockholders of record at the close of business on March 3, 2022. This represents an increase of approximately 14% over the previous quarterly dividend of 21c per share of outstanding common stock.
|
IMRA | Hot Stocks07:05 EST Imara announces FDA clearance of IND for tovinontrine - Imara announced that the U.S. Food and Drug Administration, FDA, cleared the investigational new drug, IND, application for tovinontrine, IMR-687, to commence clinical development for the treatment of heart failure with preserved ejection fraction. Imara plans to initiate a Phase 2 trial in the second quarter of 2022 to evaluate tovinontrine in patients 45 years of age or older with persistent HFpEF symptoms. "We are excited to bring our deep expertise in clinical development and operations to patients suffering from HFpEF," said Rahul Ballal, Ph.D., President and Chief Executive Officer of Imara. "We expect to initiate the Phase 2 trial in the second quarter of 2022, with a design that focuses on identifying HFpEF patients with high PDE9 expression, creating a targeted approach in this prevalent disease. With tovinontrine we believe we have the best-in-class PDE9 inhibitor for evaluation in this patient population, with in vitro data demonstrating superior potency and selectivity, as well as minimal brain penetration when compared to other PDE9 inhibitors." Imara's Phase 2 HFpEF trial will be a randomized, placebo-controlled study of approximately 170 patients 45 years of age or older with enriched PDE9 expression and persistent symptoms of HFpEF. Trial subjects will be dosed for 16 weeks. The primary endpoint will be change in NT-proBNP, with secondary endpoints that include safety and tolerability as well as quality of life measures.
|
CHK CLR | Hot Stocks07:05 EST Chesapeake to acquire Chief E&D Holdings, interests Tug Hill affiliates - The company signed definitive agreements to acquire Chief E&D Holdings and associated non-operated interests held by affiliates of Tug Hill, for $2B in cash and approximately 9.44M common shares. Chief and Tug Hill hold high quality producing assets and an inventory of premium drilling locations(1) in the prolific Marcellus Shale in Northeast Pennsylvania. The cash portion of the transaction will be financed with cash on hand and the use of the company's revolving credit facility. The transaction, which is subject to customary closing conditions, including certain regulatory approvals, is expected to close by the end of the first quarter of 2022. Chesapeake (CHK) also signed an agreement to sell its Powder River Basin assets in Wyoming to Continental Resources, Inc. (CLR) for approximately $450M in cash. The transaction, which is subject to certain customary closing conditions, is expected to close in the first quarter of 2022. At closing, net proceeds from the sale will go toward the purchase price of the Chief acquisition. Under the terms of the Chief and Tug Hill agreements, which were unanimously approved by Chesapeake's Board of Directors and also approved by Chief and Tug Hill, Chesapeake will acquire approximately 113,000 net Marcellus acres (greater than90% held by production). Assuming an April 1, 2022 closing date, the asset is currently projected to produce approximately 835 million cubic feet of net gas per day for nine months in 2022 and generate about $500M in 2022 projected adjusted EBITDAX (including acquired hedges) at current commodity strip prices. The company's Powder River Basin assets include approximately 172,000 net acres and 350 operated wells in southeastern Wyoming. Fourth quarter 2021 Powder River Basin volumes are expected to average approximately 19,000 barrels of oil equivalent per day, approximately 58% of which was crude oil and natural gas liquids. .
|
VZ | Hot Stocks07:03 EST Verizon CEO says 'laser focused' on executing 5G strategy - "2021 was a transformational year for Verizon that will serve as a catalyst for us," said Verizon Chairman and CEO Hans Vestberg. "We delivered on all of our goals in 2021 and made great progress on our five paths of growth, finishing the year with strong operating and financial momentum. As we move into 2022, we have the necessary assets to realize our strategy that we laid out in 2019. We are laser focused on executing our 5G strategy and providing value to our customers, shareholders, employees, and society, as 2022 will be the most exciting year yet for Verizon."
|
MTNB | Hot Stocks06:48 EST Matinas BioPharma provides update on its ongoing programs - Matinas BioPharma Holdings is providing a business update on each of its ongoing programs. "We made tremendous progress in 2021, completely transitioning our Company and significantly advancing our LNC platform technology," commented Jerome D. Jabbour, CEO. "Despite the resurgence of COVID-19 with both Delta and Omicron variants, our team was able to deliver compelling data for MAT2203 in the first three cohorts of the EnACT trial, which then facilitated an important and highly productive End of Phase 2 meeting with the FDA in December of 2021. Based upon FDA's support and feedback, we are preparing to expand the EnACT trial to provide additional confirmatory data in support of MAT2203 as step-down therapy for induction treatment, which we believe could position us to submit a New Drug Application in late 2023." The company provided updates on MAT2203 Program; LNC Platform Collaborations; MAT2501 Program; and LYPDISO Program.
|
PFE BNTX | Hot Stocks06:47 EST BioNTech, Pfizer to evaluate Omicron-based COVID-19 vaccine for ages 18-55 - Pfizer (PFE) and BioNTech (BNTX) announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age. The study will have three cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an Omicron-based vaccine. The study will draw upon some participants from the companies' Phase 3 COVID-19 booster study and is part of their ongoing efforts to address Omicron and determine the potential need for variant-based vaccines.
|
CS | Hot Stocks06:46 EST Credit Suisse provides trading update, warns of slowdown - Credit Suisse announced that the reported profits for the fourth quarter 2021 will be negatively impacted by litigation provisions of approximately CHF 500M, partly offset by gains on real estate sales of CHF 225M. These litigation provisions have been incurred in respect of a number of cases where the group has more proactively pursued settlements and primarily relate to legacy litigation matters from its investment banking business. Before deduction of the already announced approximately CHF 1.6B goodwill impairment for the Group, of which approximately CHF 1.5B in the Investment Bank division and approximately CHF 0.1B in the Asia Pacific division, this is expected to result in a reported pre-tax income/(loss) for the Group of approximately breakeven for the fourth quarter 2021. "We have seen a reduction in transaction-based revenues in the Investment Bank and our wealth management businesses. This reflects the usual seasonal slowdown but, in addition, business activity reflects the reversion to more normal trading conditions after the exceptional environment that prevailed for most of 2020 and 2021. Combined with the reduction in our overall risk appetite, including our decision to substantially exit our prime services business, this has resulted in a loss for the fourth quarter 2021 in the Investment Bank division," the company said. In its wealth management businesses, there has been a significant slowdown in transaction activity in the International Wealth Management and Asia Pacific divisions, with the latter also reflecting client de-leveraging mainly due to the adverse market conditions in Asia. As a consequence, fourth-quarter 2021 net new assets for the company's wealth management businesses will be modestly negative, albeit more than offset by inflows in its Asset Management business. With regard to the company's capital position, its year-end 2021 Group CET1 ratio is expected to exceed its ambition of 14%, while its year-end 2021 Tier 1 leverage ratio is expected to exceed 6%.
|
RHHBY | Hot Stocks06:41 EST Roche's Evrysdi granted FDA priority review for pre-symptomatic babies with SMA - Roche announced that the U.S. Food and Drug Administration has granted priority review of a supplemental new drug application, or sNDA, for the use of Evrysdi to treat pre-symptomatic babies under two months of age with spinal muscular atrophy, or SMA. The sNDA submission incorporates interim data from the RAINBOWFISH study, which shows the majority of pre-symptomatic babies treated with Evrysdi achieved key milestones such as sitting, standing, walking and maintained the ability to swallow following 12 months of treatment. "Treating very young babies with Evrysdi before SMA symptoms arise may help them to achieve milestones such as standing and walking within timeframes typical of healthy infants. Extending treatment access for the youngest members of the SMA community is crucial and we look forward to working with the FDA on this application," said Levi Garraway, M.D., Ph. D., Roche's Chief Medical Officer and Head of Global Product Development.
|
MTNB | Hot Stocks06:40 EST Matinas BioPharma reports $49.9M in cash and equivalents at end of FY21 - The Company's preliminary, unaudited estimate of cash, cash equivalents and marketable securities at December 31, 2021, is approximately $49.9M, subject to completion of the audit of the Company's consolidated financial statements for the year ended December 31, 2021. This compares to $58.7M at December 31, 2020. Based on current projections, the Company believes that cash on hand is sufficient to fund planned operations through 2023.
|
GMAB JNJ | Hot Stocks06:39 EST Genmab reports FY21 worldwide net sales of DARZALEX $6.023B - Genmab (GMAB) announced that worldwide net trade sales of DARZALEX, including sales of the subcutaneous formulation, as reported by Johnson & Johnson (JNJ) were $6.023B in 2021. Net trade sales were $3.169B in the U.S. and $2.854B in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC formulations, under the exclusive worldwide license to Janssen Biotech to develop, manufacture and commercialize daratumumab. As previously announced, Janssen is reducing its royalty payments to Genmab by what it claims to be Genmab's share of Janssen's royalty payments to Halozyme, cf. company announcement No. 39 of September 22, 2020.
|
VSCO | Hot Stocks06:36 EST Victoria's Secret announces partnership with Regina Miracle International - Victoria's Secret & Co. announced a partnership agreement with Regina Miracle International related to its existing company-owned business in China. Victoria's Secret and Regina Miracle have formed a joint venture, or JV, to operate all Victoria's Secret stores and the related online business in China. Under the terms of the agreement, Victoria's Secret will own 51% of the JV with Regina Miracle owning the remaining 49 percent. Based on the Company's financial review of its China business and the terms of the JV agreement agreed upon by both parties, the Company does not anticipate this proposed transaction to have a material impact on the previously affirmed operating income and earnings per share guidance for the Q4 of FY21. The agreement is subject to regulatory clearance which is anticipated to occur in the Q1 of FY22. At such time, the transaction will be completed and the Company will receive $45 million in cash from Regina Miracle as consideration for its investment in the JV.
|
CDXC | Hot Stocks06:34 EST ChromaDex reports results from clinical trial on its Niagen ingredient - ChromaDex announced results of the 18th clinical trial on its flagship Niagen ingredient with promising, peer-reviewed findings reported in the Journal of Clinical Investigation. The study investigated the anti-inflammatory effects of ChromaDex's proprietary NR ingredient in monocytes extracted from two groups: young, healthy subjects and patients diagnosed with systemic lupus erythematosus, or SLE. The study was conducted as part of the ChromaDex External Research Program and adds to a growing body of clinical evidence supporting the potential anti-inflammatory effects of NR supplementation. Results showed that increasing NAD+ levels through NR supplementation reduced Type-I interferon, or IFN, signaling in human monocytes both in vivo in a young, healthy population and ex vivo in monocytes extracted from control subjects and SLE patients. "The results from this pilot study showing an immunomodulatory effect of NR through decreased IFN levels are promising; however, more research is needed to understand the implications of NR supplementation for patients with autoimmune disorders like lupus," said Andrew Shao, Senior Vice President of Global Regulatory & Scientific Affairs at ChromaDex. "We look forward to furthering this important research." This study is supported by grants from the National Heart, Lung, and Blood Institute's Division of Intramural Research and the National Institute of Arthritis and Musculoskeletal and Skin Diseases' Division of Intramural Research, both part of NIH.
|
SYK VCRA | Hot Stocks06:34 EST Stryker commences $79.25 per share cash offer for Vocera shares - Stryker (SYK) announced that it is commencing, through a wholly owned subsidiary, Voice Merger Sub Corp., a cash tender offer to purchase all outstanding shares of common stock of Vocera Communications (VCRA) for $79.25 per share in cash. The offer is being made pursuant to the previously announced merger agreement, dated as of January 6, among Stryker, Voice Merger Sub Corp. and Vocera. The tender offer is scheduled to expire at one minute past 11:59 p.m. Eastern Time, on February 22, unless extended in accordance with the terms of the merger agreement. The tender offer is subject to various conditions, including a minimum tender of at least a majority of outstanding shares of Vocera common stock, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. The transaction is expected to close in the first quarter, as previously announced.
|
BW | Hot Stocks06:31 EST Babcock & Wilcox's renewable segment awarded $11M contract for biomass boiler - Babcock & Wilcox announced that its B&W Renewable segment has been awarded a contract for more than $11M to design, manufacture, supply, and install boiler equipment for a biomass boiler in Canada. B&W Renewable will replace pressure parts for the boiler and upgrade the design of its wood feed and air systems. Babcock & Wilcox Canada will provide the installation services.
|
JNJ | Hot Stocks06:27 EST Johnson & Johnson reports Q4 adjusted EPS $2.13, consensus $2.12 - Reports Q4 revenue $24.8B, consensus $25.29B. "Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers" said Joaquin Duato, CEO. "Given our strong results, financial profile, and innovative pipeline we are well positioned for success in 2022 and beyond."
|
GE | Hot Stocks06:26 EST GE: Aviation continues to evaluate, manage impact of omicron
|
GE | Hot Stocks06:25 EST General Electric to provide additional details on 2022 outlook on March 10
|
GE | Hot Stocks06:24 EST General Electric sees FY22 free cash flow $5.5B-$6.5B
|
GE | Hot Stocks06:23 EST General Electric CEO Culp: Orders for the year were up double digits - GE Chairman and CEO H. Lawrence Culp, Jr. said, "2021 was an important year for the GE team, marked by significant strategic, operational, and financial progress. We delivered solid margin, EPS, and free cash flow performance in 2021, exceeding our outlook. Orders for the year were up double digits, supporting faster growth going forward, while supply chain challenges, commercial selectivity, and uncertainty surrounding the U.S. wind production tax credit impacted our top-line." Culp continued, "We're seeing real momentum and opportunities for sustainable profitable growth from near-term improvements in GE's businesses, especially as Aviation recovers and our end markets strengthen. Our dramatic debt reduction means we can further intensify efforts to strengthen our operations and play offense, setting us up to deliver between $5.5 to $6.5 billion free cash flow in 2022 and more than $7 billion in 2023. As we lay the groundwork to create three independent companies focused on critical global needs, we're encouraged by the support from our customers, employees, and investors. We're confident that our businesses will deliver long-term growth and value."
|
GE | Hot Stocks06:23 EST General Electric reports Q4 Industrial organic revenues $19.6B
|
EFTR | Hot Stocks06:10 EST eFfector Therapeutics discontinuing trial of tomivosertib as add-on in NSCLC - The company states: "eFFECTOR Therapeutics announced multiple pipeline updates for its ongoing development programs, as well as the establishment of an investment agreement with Lincoln Park Capital for a commitment of up to $50 million over 36 months. In the randomized Phase 2b KICKSTART trial of tomivosertib in combination with pembrolizumab in NSCLC, a new cohort has been added to evaluate frontline maintenance in patients with PD-L1 greater than or equal to1%, an estimated $5 billion potential U.S. market opportunity. Additionally, the company is discontinuing development of tomivosertib in patients who have already progressed on pembrolizumab monotherapy. Topline data from the ongoing frontline cohort in patients with PD-L1greater than50% and the new frontline maintenance cohort in patients with PD-L1greater than1% in the KICKSTART trial are now expected in the first half 2023. Separately, in the Phase 2a trial evaluating zotatifin in patients with solid tumors, the company dosed patients in two new expansion cohorts... Upon continued evaluation of the evolving treatment landscape, eFFECTOR has updated its portfolio strategy for tomivosertib to address a much broader patient population, significantly increasing the market potential for this product candidate. eFFECTOR has updated the design of its double-blind, randomized Phase 2b KICKSTART trial of tomivosertib in NSCLC to include a new cohort, which will enroll patients with PD-L1 greater than or equal to1% who have initiated frontline therapy with pembrolizumab combined with platinum-based chemotherapy. This cohort will enroll approximately 60 patients with PD-L1 greater than or equal to1% NSCLC immediately after they complete the platinum chemotherapy phase (4-6 cycles) of their frontline treatment without disease progression. Patients in this cohort will be randomized 1:1 to standard-of-care maintenance therapy plus tomivosertib in the treatment group versus standard-of-care maintenance plus placebo in the control group. Standard-of-care maintenance therapy is defined as pembrolizumab + pemetrexed in non-squamous NSCLC and pembrolizumab in squamous NSCLC. Enrollment continues in the frontline PD-L1 greater than or equal to50% cohort in the KICKSTART trial, which will evaluate approximately 60 patients, but has been slower than originally anticipated. Reasons for slow enrollment include the impact of COVID-19 on site operations and an evolving treatment landscape with greater than anticipated use of chemotherapy + pembrolizumab as frontline therapy. The company has taken multiple steps to drive enrollment, including increasing the number of trial sites and continuing emphasis on the importance of PD-L1 testing to select optimal frontline therapy, especially for patients with PD-L1 greater than or equal to50% who may be managed using a chemotherapy-free regimen. The company believes these mitigation efforts, combined with our patient and physician outreach activities, will enhance enrollment."
|
SAP | Hot Stocks06:09 EST SAP, Icertis expand partnership for enhanced contract management - SAP and Icertis announced an expanded partnership for enhanced contract management. The partnership, which includes a financial investment from SAP in Icertis, will lead to a joint product road map and deeper technological integration. Customers will have the opportunity to benefit from ICI capabilities for smart contract creation, online negotiation, AI-assisted risk identification, obligation management and contract-driven insights for decision support while operating their core source-to-pay and lead-to-cash processes within SAP solutions.
|
CAAS | Hot Stocks06:07 EST China Automotive enters agreement with Scania to develop eRCB steering systems - China Automotive announced that it has entered into an agreement with Scania to develop eRCB steering systems for Scania's trucks and buses. This eRCB steering system is a fully electric intelligent steering system for light- and medium-duty truck and heavy-duty commercial vehicles. This eRCB steering system features a twin electric motor structure with high output torque. CAAS' proprietary AP04 driver-assist system enables vehicles to execute level-4 autonomous driving with a superior level of functionality, safety and network security. The eRCB steering system is expected to become the world's first mass-produced fully electric intelligent power steering system for commercial vehicles, which bolsters CAAS' status as a premier Tier-1 supplier to global commercial vehicle OEMs.
|
UL | Hot Stocks06:07 EST Unilever COO Nitin Paranjpe to become CTO, chief people officer
|
UL | Hot Stocks06:06 EST Unilever to cut 1,500 jobs in management shake-up - Unilever announced changes to its organizational model "to make it a simpler, more category-focused business." The company will move away from its current matrix structure and will be organized around five distinct Business Groups: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. Fernando Fernandez, EVP Latin America, has been appointed President Beauty & Wellbeing, which includes Hair Care, Skin Care, as well as Vitamins, Minerals and Supplements, and Unilever Prestige. Fabian Garcia, President North America, has been appointed President Personal Care, responsible for Skin Cleansing, Deodorants, and Oral Care. Peter ter Kulve will continue in his role as President Home Care, responsible for Fabric Care, Home & Hygiene, and Water & Air. Hanneke Faber, President Foods & Refreshment, has been appointed President Nutrition, which will be home to Scratch Cooking, Healthy Snacking, Functional Nutrition, Plant Based Meat, and Food Solutions. Matt Close, EVP Ice Cream, has been appointed President Ice Cream, a Business Group in its own right. These appointments are effective from April 1, 2022. Nitin Paranjpe, Chief Operating Officer, will take on a new role as Chief Transformation Officer & Chief People Officer, leading the business transformation, and heading the HR function. Reginaldo Ecclissato, Chief Supply Chain Officer, will lead the Supply Chain and Unilever Business Operations as Chief Business Operations Officer. Sunny Jain, President Beauty & Personal Care, has decided to leave Unilever to set up an investment fund in technology megatrends. The proposed new organization model will result in a reduction in senior management roles of around 15% and more junior management roles by 5%, equivalent to around 1,500 roles globally.
|
WST GLW | Hot Stocks06:06 EST West Pharmaceutical enters supply, technology agreement with Corning - West Pharmaceutical (WST) announced an exclusive supply and technology agreement with Corning (GLW). The new collaboration includes a multimillion-dollar investment to expand Corning's Valor Glass technology to enable advanced injectable drug packaging and delivery systems for the pharmaceutical industry with the goal of advancing patient safety and expanding access to life-saving treatments. the strategic collaboration will enable new, advanced pharmaceutical packaging solutions.
|
GOLD | Hot Stocks06:03 EST Barrick Gold's North Mara and Bulyanhulu mines produced 500,000 ounces in 2021 - North Mara and Bulyanhulu, which were moribund gold mines when Barrick took over their management two years ago, delivered a combined production of more than 500,000 ounces in 2021, meeting a key criterion for membership of the company's elite Tier One2 portfolio. The within-guidance performance was achieved with both mines retaining their ISO 45001 safety and ISO 14001 environmental accreditations, in common with Barrick's other operations. North Mara is on track to become a fully integrated mine with the planned commissioning of the Nyabirama pit during the current quarter and the scheduled commencement of the Nyabigena pit in the Q3. This is expected to add substantial resources and increased flexibility to its plan. Both mines are expected to report a significant growth of their mineral reserves, net of depletion, for 2021. Barrick has increased its footprint around Bulyanhulu through the acquisition of six highly prospective licences bordering the mine, and its exploration teams are also looking elsewhere in Tanzania for new opportunities.
|
WYNN | Hot Stocks05:56 EST Wynn Resorts, Marjan announce integrated resort development on Al Marjan Island - Marjan, RAK Hospitality and Wynn Resorts have announced a multibillion-dollar integrated resort development on the man-made Al Marjan Island in Ras Al Khaimah, United Arab Emirates. The Al Marjan Island is only 15 minutes from the Ras Al Khaimah International Airport and 45 minutes from the Dubai International Airport. Comprising four islands, Al Marjan Island has over 7.8 kilometers of beaches and 23 kilometers of waterfront in addition to hotels and residential developments. The new resort is in the initial stages of design and development and will be applying for an integrated resort license from Ras Al Khaimah Tourism Development Authority.
|
PTCT | Hot Stocks05:47 EST PTC Therapeutics receives FDA priority review for Evrysdi sNDA - PTC Therapeutics announced that the FDA has granted priority review of a supplemental new drug application for Evrysdi to expand the indication to include pre-symptomatic infants under two months old with spinal muscular atrophy, or SMA. If approved, Evrysdi would be the first medicine administered at-home for pre-symptomatic babies with SMA.
|
QGEN | Hot Stocks05:44 EST Qiagen completes U.S. government contract for COVID-19 surveillance - Qiagen announced it has completed a U.S. government contract to equip public health laboratories across the country with the QIAcuity digital PCR system to monitor the spread of the COVID-19 pandemic by testing wastewater for the presence of SARS-CoV-2 pathogens. Qiagen has shipped more than 35 QIAcuity systems to state and local health laboratories as part of a multi-million-dollar contract with the U.S. National Institutes of Health, or NIH, to supply COVID-19 instruments and consumables through the end of 2021. More than 70% of all U.S. states now have at least one laboratory - either public health or privately-owned - with a QIAcuity system for wastewater surveillance. The ultra-sensitive digital PCR platform has set new standards for delivering rapid results in two hours rather than the six required by competitive systems based on a proprietary nanoplate-based system.
|
SLI | Hot Stocks05:38 EST Standard Lithium sign LOI with KM&T for lithium chemical off-take - Standard Lithium has signed a letter of intent, or LOI, with Koch Minerals & Trading for the purchase of lithium chemical off-take and the procurement of key raw materials. The principal aim of the LOI is to develop a market-based pricing mechanism for KM&T to procure lithium hydroxide produced by Standard Lithium at the South West Arkansas Project. KM&T is also expected to assist the company with the effective procurement of key raw materials and chemical reagents. With respect to future lithium chemical off-take, this does not affect any off-take arrangements existing or contemplated with Lanxess, related to the proposed future commercial plant at their operating facilities.
|
UMC | Hot Stocks05:35 EST UMC sees FY22 capital expenditures $3B - Sees Q1 gross profit margin 40%. Sees Q1 wafer shipments flat.
|
YMM | Hot Stocks05:30 EST Full Truck Alliance reports 34.8M fulfilled orders, GTV of RMB 69.5B in Q4 - Full Truck Alliance announced that the company facilitated 34.8M fulfilled orders with gross transaction value, or GTV, of RMB 69.5B in Q4, representing 41.6% and 22.1% year-over-year growth, respectively.
|
CAPR | Hot Stocks05:27 EST Capricor Therapeutics, Nippon Shinyaku enter CAP-1002 distribution agreement - Capricor Therapeutics announced that it has entered into a partnership with Nippon Shinyaku, a Japanese pharmaceutical company listed on the TYO, for the exclusive commercialization and distribution in the United States of Capricor's lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy, or DMD, a rare neuromuscular disease with limited treatment options. Capricor's proprietary cell therapy, CAP-1002, is comprised of human allogeneic cardiosphere-derived cells, which have demonstrated positive results in patients with DMD. CAP-1002's mechanism of action is immunomodulatory and regenerative and its broad applicability makes it suitable for patients regardless of genetic mutation. HOPE-Duchenne and HOPE-2, the Phase 1 and Phase 2 clinical trials using CAP-1002 to treat late-stage DMD patients, showed statistically significant improvements in upper limb and/or cardiac function in the treatment groups. HOPE-3, the Phase 3 clinical trial that will be supported by this partnership, will commence shortly and is expected to be the pivotal trial for CAP-1002 in DMD. The regulatory pathway for CAP-1002 is supported by RMAT as well as Orphan Drug Designation. If Capricor were to receive market approval for CAP-1002 by the FDA, Capricor would be eligible to receive a Priority Review Voucher based on its designation as a rare pediatric disease. Under the terms of the agreement, Capricor will be responsible for the conduct of HOPE-3 as well as the manufacturing of CAP-1002. Nippon Shinyaku will be responsible for the distribution of CAP-1002 in the United States. Capricor will sell commercial product to Nippon Shinyaku and in addition will receive a double-digit share of product revenue and additional development and sales-based milestone payments. Capricor will receive an upfront payment of $30M with potential additional milestone payments of up to $705M.
|
JPM | Hot Stocks05:24 EST JPMorgan to acquire 49% stake in Viva Wallet, terms undisclosed - JPMorgan announced that it has entered into an agreement with Viva Wallet, a European cloud-based payments fintech company, and its existing shareholders to acquire an ownership stake of approximately 49%, subject to regulatory approvals. Financial terms of the transaction were not disclosed. Founded in 2000, Viva Wallet is headquartered in Athens, Greece, and focuses on serving SMBs in 23 countries. The company built a proprietary, cloud-based payments platform that is able to offer services to merchants including tap to device technology, merchant cash advance, bill pay, expense management, virtual debit card issuance, cash disbursement, gift cards and loyalty.
|
TEDU | Hot Stocks05:21 EST Tarena receives noncompliance notification from Nasdaq - Tarena announced that it received a written notification from Nasdaq indicating that the company no longer meets the continued listing requirement of minimum Market Value of Publicly Held Shares for Nasdaq as set forth in the Nasdaq Listing Rule 5450 because the company's MVPHS for the last 30 consecutive business days was below the minimum MVPHS requirement of $15M.
|